82 FR 44079 - Significant New Use Rules on Certain Chemical Substances
ENVIRONMENTAL PROTECTION AGENCY Federal Register Volume 82, Issue 182 (September 21, 2017)
Federal Register Volume 82, Issue 182 (September 21, 2017)
| Page Range | 44079-44099 | |
| FR Document | 2017-20158 |
[Federal Register Volume 82, Number 182 (Thursday, September 21, 2017)] [Rules and Regulations] [Pages 44079-44099] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-20158] ======================================================================= ----------------------------------------------------------------------- ENVIRONMENTAL PROTECTION AGENCY 40 CFR Parts 9 and 721 [EPA-HQ-OPPT-2016-0331; FRL-9959-81] RIN 2070-AB27 Significant New Use Rules on Certain Chemical Substances AGENCY: Environmental Protection Agency (EPA). ACTION: Direct final rule. ----------------------------------------------------------------------- SUMMARY: EPA is promulgating significant new use rules (SNURs) under the Toxic Substances Control Act (TSCA) for 37 chemical substances which were the subject of premanufacture notices (PMNs). The applicable review periods for the PMNs submitted for these 37 chemical substances all ended prior to June 22, 2016 (i.e., the date on which President Obama signed into law the Frank R. Lautenberg Chemical Safety for the 21st Century Act which amends TSCA). Six of these chemical substances are subject to TSCA section 5(e) consent orders issued by EPA. This action requires persons who intend to manufacture (defined by statute to include import) or process any of these 37 chemical substances for an activity that is designated as a significant new use by this rule to notify EPA at least 90 days before commencing that activity. The required notification initiates EPA's evaluation of the intended use within the applicable review period. Manufacture and processing for the significant new use is unable to commence until EPA has conducted a review of the notice, made an appropriate determination on the notice, and take such actions as are required with that determination. DATES: This rule is effective on November 20, 2017. For purposes of judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on October 5, 2017. Written adverse or critical comments, or notice of intent to submit adverse or critical comments, on one or more of these SNURs must be received on or before October 23, 2017 (see Unit VI. of the SUPPLEMENTARY INFORMATION). If EPA receives written adverse or critical comments, or notice of intent to submit adverse or critical comments, on one or more of these SNURs before October 23, 2017, EPA will withdraw the relevant sections of this direct final rule before its effective date. For additional information on related reporting requirement dates, see Units I.A., VI., and VII. of the SUPPLEMENTARY INFORMATION. ADDRESSES: Submit your comments, identified by docket identification (ID) number EPA-HQ-OPPT-2016-0331, by one of the following methods:Federal eRulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Mail: Document Control Office (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001. Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at http://www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Kenneth Moss, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW. Washington, DC 20460-0001; telephone number: (202) 564-9232; email address: moss.kenneth @epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave. Rochester, NY 14620; telephone number: (202) 554-1404; email address: [email protected]. SUPPLEMENTARY INFORMATION: I. General Information A. Does this action apply to me? You may be potentially affected by this action if you manufacture, process, or use the chemical substances contained in this rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include: Manufacturers or processors of one or more subject chemical substances (NAICS codes 325 and 324110), e.g., chemical manufacturing and petroleum refineries. This action may also affect certain entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import certification requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and orders under TSCA. Importers of chemicals subject to these SNURs must certify their compliance with the SNUR requirements. The EPA policy in support of import certification appears at 40 CFR part 707, subpart B. In addition, any persons who export or intend to export a chemical substance that is the subject of this rule on or after October 23, 2017 are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see Sec. 721.20), and must comply with the export notification requirements in 40 CFR part 707, subpart D. B. What should I consider as I prepare my comments for EPA? 1. Submitting CBI. Do not submit this information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as CBI and then identify electronically within the disk or CD-ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in [[Page 44080]] accordance with procedures set forth in 40 CFR part 2. 2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html. II. Background A. What action is the agency taking? EPA is promulgating these SNURs using direct final procedures. These SNURs will require persons to notify EPA at least 90 days before commencing the manufacture or processing of a chemical substance for any activity designated by these SNURs as a significant new use. Receipt of such notices allows EPA to assess risks that may be presented by the intended uses and, if appropriate, to regulate the proposed use before it occurs. Additional rationale and background to these rules are more fully set out in the preamble to EPA's first direct final SNUR published in the Federal Register issue of April 24, 1990 (55 FR 17376). Consult that preamble for further information on the objectives, rationale, and procedures for SNURs and on the basis for significant new use designations, including provisions for developing test data. B. What is the agency's authority for taking this action? Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a ``significant new use.'' EPA must make this determination by rule after considering all relevant factors, including the four bulleted TSCA section 5(a)(2) factors listed in Unit III. Once EPA determines that a use of a chemical substance is a significant new use, TSCA section 5(a)(1)(B) requires persons to submit a significant new use notice (SNUN) to EPA at least 90 days before they manufacture or process the chemical substance for that use (15 U.S.C. 2604(a)(1)(B)(i)). TSCA furthermore prohibits such manufacturing or processing from commencing until EPA has conducted a review of the notice, made an appropriate determination on the notice, and taken such actions as are required in association with that determination (15 U.S.C. 2604(a)(1)(B)(ii)). As described in Unit V., the general SNUR provisions are found at 40 CFR part 721, subpart A. C. Applicability of General Provisions General provisions for SNURs appear in 40 CFR part 721, subpart A. These provisions describe persons subject to the rule, recordkeeping requirements, exemptions to reporting requirements, and applicability of the rule to uses occurring before the effective date of the rule. Provisions relating to user fees appear at 40 CFR part 700. According to Sec. 721.1(c), persons subject to these SNURs must comply with the same SNUN requirements and EPA regulatory procedures as submitters of PMNs under TSCA section 5(a)(1)(A). In particular, these requirements include the information submission requirements of TSCA section 5(b) and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA receives a SNUN, EPA must either determine that the significant new use is not likely to present an unreasonable risk of injury or take such regulatory action as is associated with an alternative determination before the manufacture or processing for the significant new use can commence. If EPA determines that the significant new use is not likely to present an unreasonable risk, EPA is required under TSCA section 5(g) to make public, and submit for publication in the Federal Register, a statement of EPA's findings. III. Significant New Use Determination Section 5(a)(2) of TSCA states that EPA's determination that a use of a chemical substance is a significant new use must be made after consideration of all relevant factors, including: The projected volume of manufacturing and processing of a chemical substance. The extent to which a use changes the type or form of exposure of human beings or the environment to a chemical substance. The extent to which a use increases the magnitude and duration of exposure of human beings or the environment to a chemical substance. The reasonably anticipated manner and methods of manufacturing, processing, distribution in commerce, and disposal of a chemical substance. In addition to these factors enumerated in TSCA section 5(a)(2), the statute authorized EPA to consider any other relevant factors. To determine what would constitute a significant new use for the 37 chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, likely human exposures and environmental releases associated with possible uses, and the four bulleted TSCA section 5(a)(2) factors listed in this unit. IV. Substances Subject to This Rule EPA is establishing significant new use and recordkeeping requirements for 37 chemical substances in 40 CFR part 721, subpart E. In this unit, EPA provides the following information for each chemical substance: PMN number. Chemical name (generic name, if the specific name is claimed as CBI). Chemical Abstracts Service (CAS) Registry number (if assigned for non-confidential chemical identities). Basis for the TSCA section 5(e) consent order or, for non- TSCA section 5(e) SNURs, the basis for the SNUR (i.e., SNURs without TSCA section 5(e) consent orders). Tests recommended by EPA to provide sufficient information to evaluate the chemical substance (see Unit VIII. for more information). CFR citation assigned in the regulatory text section of this rule. The regulatory text section of this rule specifies the activities designated as significant new uses. Certain new uses, including production volume limits (i.e., limits on manufacture volume) and other uses designated in this rule, may be claimed as CBI. Unit IX. discusses a procedure companies may use to ascertain whether a proposed use constitutes a significant new use. This rule includes 6 PMN substances that are subject to ``risk- based'' consent orders under TSCA section 5(e)(1)(A)(ii)(I) where EPA determined that activities associated with the PMN substances may present unreasonable risk to human health or the environment. Those consent orders require protective measures to limit exposures or otherwise mitigate the potential unreasonable risk. The so-called ``TSCA section 5(e) SNURs'' on these PMN substances are promulgated pursuant to Sec. 721.160, and are based on and consistent with the provisions in the underlying consent orders. The TSCA section 5(e) SNURs designate as a ``significant new use'' the absence of the protective measures required in the corresponding consent orders. Where EPA determined that the PMN substance may present an unreasonable risk of injury to human health via inhalation exposure, the underlying TSCA section 5(e) consent order usually requires, among other things, that potentially exposed employees wear specified respirators unless actual measurements of the workplace air show that air-borne concentrations of the PMN substance are below a New Chemical Exposure Limit (NCEL) that is established by EPA to provide adequate protection to human health. In addition [[Page 44081]] to the actual NCEL concentration, the comprehensive NCELs provisions in TSCA section 5(e) consent orders, which are modeled after Occupational Safety and Health Administration (OSHA) Permissible Exposure Limits (PELs) provisions, include requirements addressing performance criteria for sampling and analytical methods, periodic monitoring, respiratory protection, and recordkeeping. However, no comparable NCEL provisions currently exist in 40 CFR part 721, subpart B, for SNURs. Therefore, for these cases, the individual SNURs in 40 CFR part 721, subpart E, will state that persons subject to the SNUR who wish to pursue NCELs as an alternative to the Sec. 721.63 respirator requirements may request to do so under Sec. 721.30. EPA expects that persons whose Sec. 721.30 requests to use the NCELs approach for SNURs are approved by EPA will be required to comply with NCELs provisions that are comparable to those contained in the corresponding TSCA section 5(e) consent order for the same chemical substance. This rule also includes SNURs on 31 PMN substances that are not subject to consent orders under TSCA section 5(e). These cases completed Agency review prior to June 22, 2016. Under TSCA, prior to the enactment of the Frank R. Lautenberg Chemical Safety for the 21st Century Act on June 22, 2016, EPA did not find that the use scenario described in the PMN triggered the determinations set forth under TSCA section 5(e). However, EPA does believe that certain changes from the use scenario described in the PMN could result in increased exposures, thereby constituting a ``significant new use.'' These so-called ``non- TSCA section 5(e) SNURs'' are promulgated pursuant to Sec. 721.170. EPA has determined that every activity designated as a ``significant new use'' in all non-TSCA section-5(e) SNURs issued under Sec. 721.170 satisfies the two requirements stipulated in Sec. 721.170(c)(2), i.e., these significant new use activities, ``(i) are different from those described in the premanufacture notice for the substance, including any amendments, deletions, and additions of activities to the premanufacture notice, and (ii) may be accompanied by changes in exposure or release levels that are significant in relation to the health or environmental concerns identified'' for the PMN substance. PMN Number P-05-436 Chemical name: Ethylene glycol ester of an aromatic substituted propenoic acid (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance will be as a modifier for polyester polymer. Based on structure activity relationship (SAR) analysis of test data on structurally similar substances, EPA predicts toxicity to aquatic organisms at concentrations that exceed 10 parts per billion (ppb) of the PMN substance in surface waters. As described in the PMN, releases to surface waters of the PMN substance are not expected to exceed 10 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 10 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of a fish acute toxicity test, freshwater and marine (Office of Pollution Prevention and Toxics (OPPTS) Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (Office of Chemical Safety and Pollution Prevention (OCSPP) Test Guideline 850.1010); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10961. PMN Number P-10-504 Chemical name: Phosphoric acid, metal salt (generic). CAS number: Not available. Basis for action: The PMN states that the substance will be used as a flame retardant for textiles. Based on SAR analysis of test data on analogous substances, EPA identified eye and dermal irritation as well as immunotoxicity concerns to workers from exposure to the PMN substance via the inhalation route. Additionally, based on SAR analysis of test data on analogous inorganic phosphates, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 5 ppb of the PMN substance in surface waters. For the use described in the PMN, significant releases of the substance are not expected, and worker dermal and inhalation will be minimal. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that substantial production volume increases, or use of the PMN substance other than as described in the PMN, could change exposure potential, which may cause significant adverse health and environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(ii) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a 90- day oral toxicity test (OPPTS Test Guideline 870.3100); a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (OCSPP Test Guideline 850.1010); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substance. EPA also recommends that the guidance document on aquatic toxicity testing of difficult substances and mixtures (Organisation for Economic Co-operation and Development (OECD) Test Guideline 23) be followed to facilitate solubility in the test media. CFR citation: 40 CFR 721.10962. PMN Number P-13-289 Chemical name: Alkanoic acid, tetramethylheteromonocycle ester (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as an additive component to engine lubricants. Based on test data on the PMN substance, as well as SAR analysis of test data on analogous aliphatic amines and esters, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 2 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance are not expected to result in surface water concentrations that exceed 2 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 2 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(i) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400) and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10963. [[Page 44082]] PMN Number P-13-908 Chemical name: Polyether polyester urethane phosphate (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as an additive. Based on SAR analysis of test data on analogous inorganic phosphates, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 5 ppb of the substance in surface waters for greater than 20 days per year. This 20-day criterion is derived from partial life cycle tests (daphnid chronic and fish early life stage tests) that typically range from 21 to 28 days in duration. EPA predicts toxicity to aquatic organisms may occur if releases of the substance to surface water exceed releases from manufacturing, processing, and use levels described in the PMN. For the manufacturing, processing, and use operations described in the PMN, environmental releases did not exceed 5 ppb for more than 20 days per year. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. However, EPA has determined that, if in the future there is domestic manufacture, the use changes from that described in the PMN, or if the production volume increases substantially, the potential for release to the environment may change correspondingly and can result in significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of an algal toxicity test (OCSPP Test Guideline 850.4500), with the PMN substance substituted for the phosphate nutrient in the algal growth medium, would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10964. PMN Number P-14-129 Chemical name: Propanamide, 2-hydroxy-N,N-dimethyl-. CAS number: 35123-06-9. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a solvent in pesticide formulations and solvent for fertilizers. Based on test data on the PMN substance, EPA identified concerns for solvent neurotoxicity, blood and liver toxicity, kidney effects, and developmental toxicity. For the uses described in the PMN, EPA does not expect significant dermal or inhalation occupational exposures, nor does it expect consumer exposures. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however that any use of the substance other than as described in the PMN, any use of the PMN substance without the use of dermal protection, where there is a potential for dermal exposures; or any use of the PMN substance in consumer products may cause serious human health effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(i). Recommended testing: EPA has determined that the results of a dermal penetration test (OPPTS Test Guideline 870.7600) would help characterize the human health effects of the PMN substance. CFR citation: 40 CFR 721.10965. PMN Number P-14-260 Chemical name: 1-Propene, 2-bromo-3,3,3-trifluoro-. CAS number: 1514-82-5. Effective date of TSCA section 5(e) consent order: March 7, 2016. Basis for TSCA section 5(e) consent order: The PMN states that the PMN substance will be used as a fire extinguishing agent for: Portable extinguishers (onboard aviation and all nonresidential); niche systems (aircraft, normally unoccupied systems, self-contained automatic fire extinguishing systems); and streaming systems for aircraft rescue fire fighting vehicles. Based on test data on the PMN substance, EPA predicts reproductive effects to unprotected workers from repeated inhalation exposures. The Order was issued under TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health. To protect against these risks, the consent order requires: 1. Use of personal protective equipment including a NIOSH-certified respirator with an APF of at least 10 or compliance with a NCEL of 1.0 parts per million (ppm) as an 8-hour time-weighted average, when there is a potential for inhalation exposures. 2. Hazard communication. Establishment and use of a hazard communication program, including human health precautionary statements on each label and in the Safety Data Sheet (SDS). 3. No domestic manufacture of the PMN substance. 4. Processing (including filling of hand-held fire extinguishers or fire extinguishing systems) of the PMN substance in an enclosed process. 5. Use only as either (1) total flooding agent in unoccupied spaces, specifically engine nacelles and auxiliary power units (APUs) in aircraft; or (2) streaming fire extinguishing agent for use only in handheld extinguishers in aircraft. The SNUR would designate as a ``significant new use'' the absence of these protective measures. Recommended testing: EPA has determined that inhalation monitoring data, collected according to the EPA draft Inhalation Monitoring Data Collection Guidelines (located in the docket under docket ID number EPA-HQ-OPPT-2016-0331 would help characterize the human health effects of the PMN substance. The Order's restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. CFR citation: 40 CFR 721.10966. PMN Number P-14-759 Chemical name: Pyrolysis oil product (generic). CAS number: Not available. Effective date of TSCA section 5(e) consent order: May 4, 2016. Basis for TSCA section 5(e) consent order: The PMN states that the generic (non-confidential) use of the substance is as an on-site coolant and petroleum feed-stock. Based on SAR analysis of test data on analogous benzene and alkyl benzenes, EPA identified concerns for oncogenicity, neurological effect, and blood toxicity to unprotected workers from repeated inhalation exposures. Further, based on SAR analysis of test data on analogous neutral organic chemicals, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 20 ppb of the PMN substance in surface waters. The Order was issued under TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the consent order requires: 1. Use of personal protective equipment including impervious gloves (where there is a potential for dermal exposures) and a NIOSH-certified respirator with an APF of at least 10 (where there is a potential for dermal or inhalation exposures) or compliance with a NCEL of 0.5 ppm as an 8-hour time-weighted average. 2. Manufacture, processing, or use of the PMN substance only for the use specified in the consent order. 3. No use of the PMN substance resulting in releases to surface waters concentrations that exceed 20 ppb. [[Page 44083]] The SNUR would designate as a ``significant new use'' the absence of these protective measures. Recommended testing: EPA has determined that the results of a developmental neurotoxicity test (OPPTS Test Guideline 870.6300) with a complete blood count and differential for white blood cells; inhalation monitoring data, collected according to the EPA draft Inhalation Monitoring Data Collection Guidelines (located in the docket under docket ID number EPA-HQ-OPPT-2016-0331; a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (OCSPP Test Guideline 850.1010) and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substance. The Order's restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. CFR citation: 40 CFR 721.10967. PMN Number P-15-279 Chemical name: 1-Octanamine, 7 (or 8)-(aminomethyl)-. CAS number: 1613320-81-2. Basis for action: The PMN states that the substance is used as a raw material for highly heat resistant plastic. Based on test data on the PMN substance, as well as SAR analysis of test data on analogous aliphatic amines, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 123 parts per billion of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 123 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 123 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(i) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400) and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10968. PMN Number P-15-409 Chemical name: Substituted alkanolamine ether (generic). CAS number: Not available. Effective date of TSCA section 5(e) consent order: March 3, 2016. Basis for TSCA section 5(e) consent order: The PMN states that the substance will be used as a hydrogen sulfide scavenger. The Order was issued under TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(II) based on a finding that the substance may be produced in substantial quantities and may reasonably be anticipated to enter the environment in substantial quantities, and there may be significant (or substantial) human exposure to the substance. Based on this finding, the consent order requires: 1. Risk notification. If as a result of the test data required, the company becomes aware that the PMN substances may present a risk of injury to human health or the environment, the company must incorporate this new information, and any information on methods for protecting against such risk into an SDS, within 90 days. 2. Submission of certain toxicity, physical-chemical property, and environmental fate testing on the PMN substance prior to exceeding the confidential production volume limits as specified in the consent order. The SNUR would designate as a ``significant new use'' the absence of these measures. Recommended testing: EPA has determined that the results of certain toxicity and environmental fate testing would help characterize the PMN substance. The submitter has agreed to complete the testing identified in the testing section of the consent order by the confidential limits specified. CFR citation: 40 CFR 721.10969. PMN Number P-15-583 Chemical name: Butanedioic acid, alkyl amine, dimethylbutyl ester (generic). CAS number: Not available. Effective date of TSCA section 5(e) consent order: February 8, 2016. Basis for TSCA section 5(e) consent order: The PMN states that the substance will be used as an additive to engine motor oil. Based on physical-chemical properties data, EPA predicts that the PMN substance will persist in the environment, could bioaccumulate or biomagnify, and could be toxic (PBT) to people, wild mammals, and birds. Further, based on test data on the PMN, as well as SAR analysis of analogous aliphatic amines, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substance in surface waters. The Order was issued under TSCA sections 5(e)(1)(A)(i), 5(e)(1)(A)(ii)(I), and 5(e)(1)(A)(ii)(II) based on a finding that the substance may present an unreasonable risk of injury to the environment and human health, the substance may be produced in substantial quantities and may reasonably be anticipated to enter the environment in substantial quantities, and there may be significant (or substantial) human exposure to the substance. To protect against these exposures and risks, the consent order requires: 1. Risk notification. If as a result of the test data required, the company becomes aware that the PMN substances may present a risk of injury to human health or the environment, the company must incorporate this new information, and any information on methods for protecting against such risk into an SDS, within 90 days. 2. Submission of certain toxicity, physical-chemical property, and environmental fate testing on the PMN substance prior to exceeding the confidential production volume limits as specified in the consent order. 3. No releases of the PMN substance into the waters of the United States. The SNUR would designate as a ``significant new use'' the absence of these protective measures. Recommended testing: EPA has determined that the results of certain toxicity and environmental fate testing would help characterize the PMN substance. The submitter has agreed to complete the testing identified in the testing section of the consent order by the confidential limits specified. In addition, EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400) and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. The Order's restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. CFR citation: 40 CFR 721.10970. PMN Number P-15-672 Chemical name: Carbon nanotube (generic). CAS number: Not available. Effective date of TSCA section 5(e) consent order: January 15, 2016. [[Page 44084]] Basis for TSCA section 5(e) consent order: The PMN states that the generic (non-confidential) use of the PMN substance will be in filtration media. Based on test data on analogous respirable, poorly soluble particulates and carbon nanotubes, EPA identified concerns for pulmonary toxicity and oncogenicity. Based on test data for other carbon nanotubes EPA identified concerns for environmental toxicity. The Order was issued under TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the consent order requires: 1. Use of personal protective equipment involving impervious gloves and protective clothing (where there is a potential for dermal exposure) and a NIOSH-certified respirator with N-100, P-100, or R-100 cartridges (where there is a potential for inhalation exposure). 2. Processing and use of the PMN substance only for the use specified in the consent order. 3. Processing and use of the PMN substance only as an aqueous slurry, wet form, or a contained dry form as described in the PMN. 4. No use of the PMN substance resulting in releases to surface waters and disposal of the PMN substance only by landfill or incineration. The SNUR would designate as a ``significant new use'' the absence of these protective measures. Recommended testing: EPA has determined that a two-year inhalation bioassay (OPPTS 870.4200); a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize possible health and environmental effects of the substance. Although the Order does not require these tests, the Order's restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. CFR citation: 40 CFR 721.10971. PMN Number P-15-678 Chemical name: Metal salt of mineral acid, reaction products with alumina, aluminum hydroxide, aluminum hydroxide oxide (Al(OH)O), silica, titanium oxide (TiO2) and 3-(triethoxysilyl)-1-propanamine (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as an industrial paper additive. Based on SAR analysis of test data on analogous respirable, poorly soluble particulates, EPA identified concerns for lung toxicity if inhaled based on lung overload. As described in the PMN, inhalation is expected to be minimal for this use. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substance other than as identified in the PMN may result in serious health effects. Based on this information, the PMN meets the concern criteria at Sec. 721.170(b)(3)(ii). Recommended testing: EPA has determined that the results of a 90- day inhalation toxicity test (OPPTS Test Guideline 870.3465) would help characterize the human health effects of the PMN substance. CFR citation: 40 CFR 721.10972. PMN Numbers P-15-766 and P-15-767 Chemical names: Halogenated bisphenol A, polymer with epichlorohydrin, alkenoate (generic) (P-15-766) and Halogenated bisphenol A, polymer with bisphenol A diglycidyl ether and epoxidized phenol-formaldehyde resin, alkenoate (generic) (P-15-767). CAS numbers: Not available. Basis for action: The PMNs state that the generic (non- confidential) use of the substances will be as resins for flame retardant polyester. Based on test data on the confidential impurity of the PMN substance, EPA identified concerns for chronic toxicity effects to workers and the general population exposed to the PMN substances. Further, based on the confidential impurity, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 20 ppb of the impurity in surface waters. As described in the PMNs, EPA does not expect significant occupational exposures, general population exposures, nor releases of the substance to result in surface water concentrations that exceed 20 ppb of the impurity in surface waters. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substances may present an unreasonable risk. EPA has determined, however, that any consumer use, any use other than as described in the PMNs, or any increase in production volume over 10,000 kg/yr may result in serious human health and significant adverse environmental effects. Based on this information, the PMN substances meet the concern criteria at Sec. 721.170(b)(5)(ii). Recommended testing: EPA has determined that the results of a combined repeated dose toxicity test (OECD Test Guideline 422) with the reproduction/developmental toxicity screening test; a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substances. CFR citations: 40 CFR 721.10973 (P-15-766) and 40 CFR 721.10974 (P- 15-767). PMN Number P-16-14 Chemical name: Silicon, tris[dialkyl phenyl]-dialkyl-dioxoalkane- naphthalene disulfonate (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as an ink additive. Based on test data on the PMN substance, as well as SAR analysis of test data on analogous diketones, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 6 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 6 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 6 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(i) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a ready biodegradability test (OECD Test Guideline 301); a fish early-life state toxicity test (OCSPP Test Guideline 850.1400); and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10975. PMN Number P-16-40 Chemical name: Tar acids fraction (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a polymer. Based on test data on the PMN substance, as well as SAR analysis of test data on analogous phenols, EPA predicts toxicity to [[Page 44085]] aquatic organisms may occur at concentrations that exceed 45 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 45 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 45 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(i) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life state toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10976. PMN Numbers P-16-59 and P-16-60 Chemical names: Dialkyl fattyalkylamino propanamide alkylamine (generic) (P-16-59) and Fattyalkylaminopropanoate ester (generic) (P- 16-60). CAS numbers: Not available. Basis for action: The PMNs state that the substances will be used as chemical intermediates. Based on data on the PMN substances, as well as SAR analysis of test data on analogous aliphatic amines, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substances in surface waters. As described in the PMNs, releases of the substance are not expected to result in surface water concentrations that exceed 1 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substances resulting in surface water concentrations exceeding 1 ppb may cause significant adverse environmental effects. Based on this information, the PMN substances meets the concern criteria at Sec. 721.170(b)(4)(i). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the environmental effects of the PMN substances. CFR citations: 40 CFR 721.10977 (P-16-59) and 40 CFR 721.10978 (P- 16-60). PMN Number P-16-70 Chemical Name: Boron sodium oxide (B5NaO8), labeled with boron-10. CAS Number: 200443-98-7. Basis for Action: The PMN states that this substance is to be used as an emergency shutdown coolant in boiling water reactors. Based on test data for boron compounds, the EPA identified potential human health concerns regarding reproductive effects, developmental toxicity, neurotoxicity, and blood effects from exposure to the PMN substance via inhalation exposure. Further, based on SAR analysis of test data on boron compounds, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1,240 ppb of the PMN substance in surface waters for greater than 20 days per year. This 20-day criterion is derived from partial life cycle tests (daphnid chronic and fish early life stage tests) that typically range from 21 to 28 days in duration. EPA predicts toxicity to aquatic organisms may occur if releases of the substance to surface water, from uses other than as described in the PMN, exceed releases from the use described in the PMN. For the use described in the PMN, inhalation and dermal exposures are expected to be minimal and environmental releases did not exceed 1,240 ppb for more than 20 days per year. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substance other than as listed in the PMN may result in serious human health and significant adverse environmental effects. Based on this information, the PMN substance meet the concern criteria at Sec. 721.170(b)(3)(ii) and (b)(4)(ii). Recommended Testing: EPA has determined that the results of a reproductive/developmental toxicity screening test (OPPTS 870.3550/OECD Test Guideline 421); a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (OPPTS Test Guideline 850.1010); and algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substance. CFR Citation: 40 CFR 721.10979. PMN Number P-16-94 Chemical name: Perfluoropolyether modified organosilane (generic). CAS number: Not available. Basis for action: The PMN states that the substance will be used as a stain-proof coating agent for touch panel. Based on physical-chemical properties data on the PMN substance, as well as SAR analysis of test data on analogous perfluorinated chemicals and potential perfluorinated degradation products, EPA identified concerns for irritation to skin, eyes, lungs, mucous membranes, lung toxicity, liver toxicity, blood toxicity, male reproductive toxicity, immunosupression, and oncogenicity. EPA has concerns that these degradation products will persist in the environment, could bioaccumulate or biomagnify, and could be toxic (PBT) to people, wild mammals, and birds. EPA predicts adverse effects to human health and the environment may occur if releases of the PMN substance to surface water at production volumes higher than described in the PMN exceed the releases expected from the production volume described in the PMN. For the described production volume in the PMN, significant environmental releases are not expected. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any substantial combined production volume increase could result in exposures which may cause serious human health and significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(1)(i)(D), (b)(3)(iii), and (b)(4)(iv). Recommended testing: EPA has determined that the results of an indirect photolysis screening test: Sunlight photolysis in waters containing dissolved humic substances (OPPTS Test Guideline 835.5270), and simulation tests to assess the primary and ultimate biodegradability of chemicals discharged to wastewater (OPPTS Test Guideline 835.3280/OECD Test Guideline 314) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10980. PMN Number P-16-95 Chemical name: Modified phenol-formaldehyde resin (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a flame retardant [[Page 44086]] additive. Based on SAR analysis of test data on analogous neutral organics, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 96 ppb of the PMN substance in surface waters. Further, based on the alcohol groups, EPA has concern for irritation to eyes, lungs, and mucous membranes. As described in the PMN, releases of the substance are not expected to result in surface water concentrations that exceed 96 ppb and exposures to workers and general population are minimal due to the use as a flame retardant additive. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that use of the substance other than as stated in the PMN or any use of the substance resulting in surface water concentrations exceeding 96 ppb may result in serious human health and significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(ii) and (b)(4)(ii). Recommended testing: EPA has determined that the results of an acute toxicity test (OPPTS Test Guideline 870.1000); a repeated dose 28-day oral toxicity study (OPPTS Test Guideline 870.3050) in rodents; a bacterial reverse mutation test (OPPTS Test Guideline 870.5100); a mammalian erythrocyte micronucleus test (OPPTS Test Guideline 870.5395); a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substance. CFR citation: 40 CFR 721.10981. PMN Number P-16-101 Chemical name: Disubstituted benzene alkanal (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance will be as a component for household products, including cleaning, fabric and air care. Based on SAR analysis of test data on analogous structurally similar substances, EPA identified concerns for developmental toxicity from dermal exposures of the PMN substance to workers and consumers. For the use described in the PMN, dermal exposures are not expected based on the use of impervious gloves, and consumer dermal exposures are expected to be minimal. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substances may present an unreasonable risk. EPA has determined, however, that any use of the PMN substance without the use of dermal protection, where there is a potential for dermal exposures, or any use of the PMN substance other than for the use specified in the PMN may result in serious human health effects. Based on this information, the PMN substance meet the concern criteria at Sec. 721.170(b)(3)(ii). Recommended testing: EPA has determined that results of a 90-day oral toxicity test (OPPTS Test Guideline 870.3100) in rats via the gavage route, and a developmental toxicity test OPPTS Test Guideline 870.3650) in rats via the gavage route would help characterize the effects of the PMN substance. CFR citation: 40 CFR 721.10982. PMN Number P-16-102 Chemical name: Phthalic anhydride, polymer with alkylene glycol and alkanepolyol, acrylate (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a coating component. Based on SAR analysis of test data on analogous acrylates, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 1 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 1 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of a water solubility test (OPPTS Test Guideline 830.7840, a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (OCSPP Test Guideline 850.1010); and algal toxicity test (OCSPP Test Guideline 850.4500); would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10983. PMN Number P-16-104 Chemical name: 2-Pyridinecarboxylic acid, 4,5-dichloro-6-(4-chloro- 2-fluoro-3-methoxyphenyl)-. CAS number: 1546765-39-2. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a feed stock for an intermediate. Based on SAR analysis of test data on analogous halopyridines, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 8 ppb of the PMN substance in surface waters. Further, based on the acid moiety, EPA has concern for irritation to eyes, lungs, and mucous membranes. As described in the PMN, releases of the substance are not expected to result in surface water concentrations that exceed 8 ppb and exposures to workers and general population are minimal due to the use as an intermediate. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that use of the substance other than as an intermediate or any use of the substance resulting in surface water concentrations exceeding 8 ppb may result in serious human health and significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(ii) and (b)(4)(ii). Recommended testing: EPA has determined that the results of an acute toxicity test (OPPTS Test Guideline 870.1000); a repeated dose 28-day oral toxicity study (OPPTS Test Guideline 870.3050) in rodents; a bacterial reverse mutation test (OPPTS Test Guideline 870.5100); a mammalian erythrocyte micronucleus test (OPPTS Test Guideline 870.5395); a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an acute invertebrate toxicity test, freshwater daphnids (OCSPP Test Guideline 850.1010); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the human health and environmental effects of the PMN substance. CFR citation: 40 CFR 721.10984. PMN Numbers P-16-136, P-16-139, and P-16-140 Chemical names: Dialkylamino alkylamide inner salt (generic). CAS numbers: Not available. Basis for action: The PMNs state that the generic (non- confidential) use of these substances is in oil production. Based on SAR analysis of test data on analogous aliphatic amines, EPA [[Page 44087]] predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substances in surface waters. As described in the PMNs, releases of these substances are not expected to result in surface water concentrations that exceed 1 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substances may present an unreasonable risk. EPA has determined, however, that any use of the substances resulting in surface water concentrations exceeding 1 ppb may cause significant adverse environmental effects. Based on this information, the PMN substances meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a mysid chronic toxicity test (OCSPP Test Guideline 850.1350); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the environmental effects of the PMN substances. Testing should be conducted on PMN substance P-16-139. CFR citation: 40 CFR 721.10985. PMN Number P-16-170 Chemical name: Nanocarbon (generic). CAS number: Not available. Effective date of TSCA section 5(e) consent order: June 21, 2016. Basis for TSCA section 5(e) consent order: The PMN states that the substance will be used as an additive to composite materials. Based on test data on analogous respirable, poorly soluble particulates and nanocarbon materials, EPA identified concerns for pulmonary toxicity and oncogenicity. Based on test data for other nanocarbon materials EPA identified concerns for environmental toxicity. The Order was issued under TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the consent order requires: 1. Use of personal protective equipment involving impervious gloves and protective clothing (where there is a potential for dermal exposure) and a NIOSH-certified respirator with N-100, P-100, or R-100 cartridges (where there is a potential for inhalation exposure). 2. Submission of a dustiness test within six months of notice of commencement. 3. Submission of a 90-day chronic inhalation study prior to exceeding the confidential production volume limit specified in the consent order. 4. Processing and use of the PMN substance only for the use specified in the consent order including no application method that generates a vapor, mist or aerosol unless the application method occurs in an enclosed process. 5. No use of the PMN substance resulting in releases to surface waters and disposal of the PMN substance only by landfill or incineration. The SNUR would designate as a ``significant new use'' the absence of these protective measures. Recommended testing: EPA has determined that the development of data on certain physical-chemical properties, as well as certain human health and environmental toxicity testing would help characterize possible effects of the substance. The submitter has agreed to provide a dustiness test (European Standard EU 15051) by six months from commencement of manufacture. In addition, the submitter has agreed not to exceed the confidential production limit without performing a 90-day inhalation toxicity test (OPPTS Test Guideline 870.3465 or OECD Test Guideline 413) in rats with a post-exposure observation period of up to 9 months (including BALF analysis, a determination of cardiovascular toxicity (clinically-based blood/plasma protein analyses), and histopathology of the heart). Although the order does not require a two-year inhalation bioassay (OPPTS Test Guideline 870.4200), a daphnid chronic toxicity test (OPPTS Test Guideline 850.1300), a fish early- life stage toxicity test (OCSPP Test Guideline 850.1400), or an algal toxicity test (OCSPP Test Guideline 850.4500), the Order's restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. CFR citation: 40 CFR 721.10986. PMN Number P-16-177 Chemical name: Barium molybdenum niobium tantalum tellurium vanadium zinc oxide. CAS number: 1440529-21-4. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a glass coating. Based on SAR analysis of test data on the analogous respirable, poorly soluble particulates, EPA identified concerns for lung effects to workers exposed to the PMN substance. As described in the PMN, worker exposure will be minimal due to the use of adequate respiratory protection. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that use of the substance without a National Institute for Occupational Safety and Health (NIOSH)-certified respirators with an assigned protection factor (APF) of at least 10, where there is potential respiratory exposure, any use other than in the PMN, or domestic manufacture may result in serious human health effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(ii). Recommended testing: EPA has determined that the results of a 90- day subchronic toxicity test (OPPTS Test Guideline 870.3465) via the inhalation route with a 60-day holding period would help characterize the human health effects of the PMN substance. CFR citation: 40 CFR 721.10987. PMN Number P-16-179 Chemical name: Alkanoic acids, esters with alkanetriol (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a grease. Based on SAR analysis of test data on analogous esters, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance are not expected to result in surface water concentrations that exceed 1 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 1 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300); and an algal toxicity test (OCSPP Test Guideline 850.4500) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10988. PMN Number P-16-182 Chemical names: Manganese, tris[.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical A); Manganese, [.mu.-(acetato-.kappa.O:.kappa.O')]bis[.mu.-(2- ethylhexanoato- [[Page 44088]] .kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7- triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical B); Manganese, bis[.mu.-(acetato-.kappa.O:.kappa.O')][.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical C); and Manganese, tris[.mu.- (acetato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7- triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical D). CAS numbers: 2020407-62-7 (P-16-182, chemical A); 2020407-63-8 (P- 16-182, chemical B); 2020407-64-9 (P-16-182, chemical C); and 2020407- 65-0 (P-16-182, chemical D). Basis for action: The PMN states that the generic (non- confidential) use of the substances will be as resins. Based on SAR analysis of test data on analogous compounds, EPA identified concerns for systemic effects to the thyroid and pituitary gland, liver toxicity, developmental and reproductive toxicity, and mutagenicity. There are also concerns for immunotoxicity, reproductive and developmental toxicity, neurotoxicity, blood effects, and kidney toxicity, and uncertain concerns for asthma and oncogenicity, based on manganese, and concerns for developmental toxicity for branched acid hydrolysis products, by analogy to valproic acid and other acids that are branched on the carbon adjacent to the acid group, all based on exposure to the PMN substances via inhalation or dermal exposure. As described in the PMN, exposure is expected to be minimal due to negligible inhalation exposures and use of adequate dermal personal protection equipment. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substances may present an unreasonable risk. EPA has determined, however, that any domestic manufacture; any manufacture of the PMN substances at a concentration greater than 10% in any formulation; or any use of the PMN substances without the use of chemical impervious gloves, where there is a potential for dermal exposures may result in serious human health effects. Based on this information, the PMN substances meet the concern criteria at 40 CFR 721.170(b)(3)(ii). Recommended testing: EPA has determined that the results of a combined repeated dose toxicity reproduction/development toxicity screening test (OECD Test Guideline 422) would help characterize the human health effects of the PMN substances. CFR citations: 40 CFR 721.10989 (P-16-182, chemical A), 40 CFR 721.10990 (P-16-182, chemical B), 40 CFR 721.10991 (P-16-182, chemical C), and 40 CFR 721.10992 (P-16-182, chemical D). PMN Number P-16-190 Chemical name: Aryl polyolefin (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance will be as a lubricant. Based on analogy to C10-13 alkyl derivatives of benzene, EPA identified concerns for reproductive and developmental toxicity to workers exposed to the PMN substance based on exposure to the PMN substance via dermal exposure. As described in the PMN, exposure is expected to be minimal due to use of adequate dermal personal protection equipment. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance may present an unreasonable risk. EPA has determined, however, that use of the substance other than as described in the PMN, or any use without the use of dermal protection where there is a potential for dermal exposures may cause serious human health effects. Based on this information, the PMN substance meets the concern criteria at 40 CFR 721.170(b)(3)(ii). Recommended testing: EPA has determined that the results of a two- generation reproduction toxicity test (OECD Test Guideline 416) would help characterize the human health effects of the PMN substance. CFR citation: 40 CFR 721.10993. PMN Number P-16-260 Chemical name: Melamine nitrate (generic). CAS number: Not available. Basis for action: The PMN states that the generic (non- confidential) use of the substance is as a gas generant for automobile air bag inflators. Based on test data on the PMN substance, as well as SAR analysis of test data on analogous melamines, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 14 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 14 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 14 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(i) and (b)(4)(ii). Recommended testing: EPA has determined that the results of a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400) and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10994. PMN Number P-16-272 Chemical name: Lecithins, soya, hydrogenated. CAS number: 308068-11-3. Basis for action: The PMN states that the generic (non- confidential) use of the substance is an ingredient in a formulated product. Based on SAR analysis of test data on analogous amphoteric surfactants, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb of the PMN substance in surface waters. As described in the PMN, releases of the substance during the use described in the PMN are not expected to result in surface water concentrations that exceed 1 ppb. Therefore, EPA has not determined that the proposed manufacturing, processing, or use of the substance for the use described in the PMN may present an unreasonable risk. EPA has determined, however, that any use of the substance resulting in surface water concentrations exceeding 1 ppb may cause significant adverse environmental effects. Based on this information, the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii). Recommended testing: EPA has determined that the results of a fish acute toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075); an aquatic invertebrate acute toxicity test, freshwater daphnids (OCSPP Test Guideline 850.1010); an algal toxicity test (OCSPP Test Guideline 850.4500); a fish early-life stage toxicity test (OCSPP Test Guideline 850.1400); and a daphnid chronic toxicity test (OCSPP Test Guideline 850.1300) would help characterize the environmental effects of the PMN substance. CFR citation: 40 CFR 721.10995. [[Page 44089]] V. Rationale and Objectives of the Rule A. Rationale During review of the PMNs submitted for the chemical substances that are subject to these SNURs, EPA concluded that for 6 of the 37 chemical substances, regulation was warranted under TSCA section 5(e), pending the development of information sufficient to make reasoned evaluations of the health or environmental effects of the chemical substances. The basis for such findings is outlined in Unit IV. Based on these findings, TSCA section 5(e) consent orders requiring the use of appropriate exposure controls were negotiated with the PMN submitters. The SNUR provisions for these chemical substances are consistent with the provisions of the TSCA section 5(e) consent orders. These SNURs are promulgated pursuant to Sec. 14;721.160 (see Unit VI.). In the other 31 cases, where the uses are not regulated under a TSCA section 5(e) consent order, EPA determined that one or more of the criteria of concern established at Sec. 14;721.170 were met, as discussed in Unit IV. B. Objectives EPA is issuing these SNURs for specific chemical substances which have undergone premanufacture review because the Agency wants to achieve the following objectives with regard to the significant new uses designated in this rule: EPA will receive notice of any person's intent to manufacture or process a listed chemical substance for the described significant new use before that activity begins. EPA will have an opportunity to review and evaluate data submitted in a SNUN before the notice submitter begins manufacturing or processing a listed chemical substance for the described significant new use. EPA will be able to either determine that the prospective manufacture or processing is not likely to present an unreasonable risk, or to take necessary regulatory action associated with any other determination, before the described significant new use of the chemical substance occurs. EPA will ensure that all manufacturers and processors of the same chemical substance that is subject to a TSCA section 5(e) consent order are subject to similar requirements. Issuance of a SNUR for a chemical substance does not signify that the chemical substance is listed on the TSCA Chemical Substance Inventory (TSCA Inventory). Guidance on how to determine if a chemical substance is on the TSCA Inventory is available on the Internet at http://www.epa.gov/opptintr/existingchemicals/pubs/tscainventory/index.html. VI. Direct Final Procedures EPA is issuing these SNURs as a direct final rule, as described in Sec. 14;721.160(c)(3) and Sec. 14;721.170(d)(4). In accordance with Sec. 14;721.160(c)(3)(ii) and Sec. 14;721.170(d)(4)(i)(B), the effective date of this rule is November 20, 2017 without further notice, unless EPA receives written adverse or critical comments, or notice of intent to submit adverse or critical comments before October 23, 2017. If EPA receives written adverse or critical comments, or notice of intent to submit adverse or critical comments, on one or more of these SNURs before October 23, 2017, EPA will withdraw the relevant sections of this direct final rule before its effective date. EPA will then issue a proposed SNUR for the chemical substance(s) on which adverse or critical comments were received, providing a 30-day period for public comment. This rule establishes SNURs for a number of chemical substances. Any person who submits adverse or critical comments, or notice of intent to submit adverse or critical comments, must identify the chemical substance and the new use to which it applies. EPA will not withdraw a SNUR for a chemical substance not identified in the comment. VII. Applicability of the Significant New Use Designation To establish a significant new use, EPA must determine that the use is not ongoing. The chemical substances subject to this rule have undergone premanufacture review. In cases where EPA has not received a notice of commencement (NOC) and the chemical substance has not been added to the TSCA Inventory, no person may commence such activities without first submitting a PMN. Therefore, for chemical substances for which an NOC has not been submitted EPA concludes that the designated significant new uses are not ongoing. When chemical substances identified in this rule are added to the TSCA Inventory, EPA recognizes that, before the rule is effective, other persons might engage in a use that has been identified as a significant new use. However, TSCA section 5(e) consent orders have been issued for 6 chemical substances, and the PMN submitters are prohibited by the TSCA section 5(e) consent orders from undertaking activities which would be designated as significant new uses. The identities of 26 of the 37 chemical substances subject to this rule have been claimed as confidential and EPA has received no post-PMN bona fide submissions (per Sec. Sec. 720.25 and 721.11). Based on this, the Agency believes that it is highly unlikely that any of the significant new uses described in the regulatory text of this rule are ongoing. Therefore, EPA designates June 1, 2017 which is the date of public release by posting on EPA's Web site, as the cutoff date for determining whether the new use is ongoing. This designation varies slightly from EPA's past practice of designating the date of Federal Register publication as the date for making this determination. The objective of EPA's approach has been to ensure that a person could not defeat a SNUR by initiating a significant new use before the effective date of the direct final rule. In developing this rule, EPA has recognized that, given EPA's practice of now posting rules on its Web site a week or more in advance of Federal Register publication, this objective could be thwarted even before that publication. Thus, EPA has slightly modified its approach in this rulemaking and plans to follow this modified approach in future significant new use rulemakings. Persons who begin commercial manufacture or processing of the chemical substances for a significant new use identified as of that date would have to cease any such activity upon the effective date of the final rule. To resume their activities, these persons would have to first comply with all applicable SNUR notification requirements and wait until the notice review period, including any extensions, expires. If such a person met the conditions of advance compliance under Sec. 721.45(h), the person would be considered exempt from the requirements of the SNUR. Consult the Federal Register document of April 24, 1990 for a more detailed discussion of the cutoff date for ongoing uses. VIII. Development and Submission of Information EPA recognizes that TSCA section 5 does not require developing any particular new information (e.g., generating test data) before submission of a SNUN. There is an exception: Development of test data is required where the chemical substance subject to the SNUR is also subject to a rule, order or consent agreement under TSCA section 4 (see TSCA section 5(b)(1)). In the absence of a TSCA section 4 test rule covering the chemical [[Page 44090]] substance, persons are required only to submit information in their possession or control and to describe any other information known to or reasonably ascertainable by them (see 40 CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the authority to require appropriate testing. In cases where EPA issued a TSCA section 5(e) consent order that requires or recommends certain testing, Unit IV. lists those tests. Unit IV. also lists recommended testing for non-TSCA section 5(e) SNURs. Descriptions of tests are provided for informational purposes. EPA strongly encourages persons, before performing any testing, to consult with the Agency pertaining to protocol selection. To access the OCSPP test guidelines referenced in this document electronically, please go to http://www.epa.gov/ocspp and select ``Test Methods and Guidelines.'' The Organisation for Economic Co-operation and Development (OECD) test guidelines are available from the OECD Bookshop at http://www.oecdbookshop.org or SourceOECD at http://www.sourceoecd.org. In the TSCA section 5(e) consent orders for several of the chemical substances regulated under this rule, EPA has established production volume limits in view of the lack of data on the potential health and environmental risks that may be posed by the significant new uses or increased exposure to the chemical substances. These limits cannot be exceeded unless the PMN submitter first submits the results of toxicity tests that would permit a reasoned evaluation of the potential risks posed by these chemical substances. Under recent TSCA section 5(e) consent orders, each PMN submitter is required to submit each study at least 14 weeks (earlier TSCA section 5(e) consent orders required submissions at least 12 weeks) before reaching the specified production limit. Listings of the tests specified in the TSCA section 5(e) consent orders are included in Unit IV. The SNURs contain the same production volume limits as the TSCA section 5(e) consent orders. Exceeding these production limits is defined as a significant new use. Persons who intend to exceed the production limit must notify the Agency by submitting a SNUN at least 90 days in advance of commencement of non- exempt commercial manufacture or processing. The recommended tests specified in Unit IV. may not be the only means of addressing the potential risks of the chemical substance. However, submitting a SNUN without any test data may increase the likelihood that EPA will take action under TSCA section 5(e), particularly if satisfactory test results have not been obtained from a prior PMN or SNUN submitter. EPA recommends that potential SNUN submitters contact EPA early enough so that they will be able to conduct the appropriate tests. SNUN submitters should be aware that EPA will be better able to evaluate SNUNs which provide detailed information on the following: Human exposure and environmental release that may result from the significant new use of the chemical substances. Potential benefits of the chemical substances. Information on risks posed by the chemical substances compared to risks posed by potential substitutes. IX. Procedural Determinations By this rule, EPA is establishing certain significant new uses which have been claimed as CBI subject to Agency confidentiality regulations at 40 CFR part 2 and 40 CFR part 720, subpart E. Absent a final determination or other disposition of the confidentiality claim under 40 CFR part 2 procedures, EPA is required to keep this information confidential. EPA promulgated a procedure to deal with the situation where a specific significant new use is CBI, at Sec. 721.1725(b)(1). Under these procedures a manufacturer or processor may request EPA to determine whether a proposed use would be a significant new use under the rule. The manufacturer or processor must show that it has a bona fide intent to manufacture or process the chemical substance and must identify the specific use for which it intends to manufacture or process the chemical substance. If EPA concludes that the person has shown a bona fide intent to manufacture or process the chemical substance, EPA will tell the person whether the use identified in the bona fide submission would be a significant new use under the rule. Since most of the chemical identities of the chemical substances subject to these SNURs are also CBI, manufacturers and processors can combine the bona fide submission under the procedure in Sec. 14;721.1725(b)(1) with that under Sec. 14;721.11 into a single step. If EPA determines that the use identified in the bona fide submission would not be a significant new use, i.e., the use does not meet the criteria specified in the rule for a significant new use, that person can manufacture or process the chemical substance so long as the significant new use trigger is not met. In the case of a production volume trigger, this means that the aggregate annual production volume does not exceed that identified in the bona fide submission to EPA. Because of confidentiality concerns, EPA does not typically disclose the actual production volume that constitutes the use trigger. Thus, if the person later intends to exceed that volume, a new bona fide submission would be necessary to determine whether that higher volume would be a significant new use. X. SNUN Submissions According to Sec. 14;721.1(c), persons submitting a SNUN must comply with the same notification requirements and EPA regulatory procedures as persons submitting a PMN, including submission of test data on health and environmental effects as described in 40 CFR 720.50. SNUNs must be submitted on EPA Form No. 7710-25, generated using e-PMN software, and submitted to the Agency in accordance with the procedures set forth in 40 CFR 720.40 and Sec. 721.25. E-PMN software is available electronically at http://www.epa.gov/opptintr/newchems. XI. Economic Analysis EPA has evaluated the potential costs of establishing SNUN requirements for potential manufacturers and processors of the chemical substances subject to this rule. EPA's complete economic analysis is available in the docket under docket ID number EPA-HQ-OPPT-2016-0331. XII. Statutory and Executive Order Reviews A. Executive Order 12866 This action establishes SNURs for several new chemical substances that were the subject of PMNs, or TSCA section 5(e) consent orders. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866, entitled ``Regulatory Planning and Review'' (58 FR 51735, October 4, 1993). B. Paperwork Reduction Act (PRA) According to PRA (44 U.S.C. 3501 et seq.), an agency may not conduct or sponsor, and a person is not required to respond to a collection of information that requires OMB approval under PRA, unless it has been approved by OMB and displays a currently valid OMB control number. The OMB control numbers for EPA's regulations in title 40 of the CFR, after appearing in the Federal Register, are listed in 40 CFR part 9, and included on the related collection instrument or form, if applicable. EPA is amending the table in 40 CFR part 9 to list the OMB approval number for the information collection [[Page 44091]] requirements contained in this action. This listing of the OMB control numbers and their subsequent codification in the CFR satisfies the display requirements of PRA and OMB's implementing regulations at 5 CFR part 1320. This Information Collection Request (ICR) was previously subject to public notice and comment prior to OMB approval, and given the technical nature of the table, EPA finds that further notice and comment to amend it is unnecessary. As a result, EPA finds that there is ``good cause'' under section 553(b)(3)(B) of the Administrative Procedure Act (5 U.S.C. 553(b)(3)(B)) to amend this table without further notice and comment. The information collection requirements related to this action have already been approved by OMB pursuant to PRA under OMB control number 2070-0012 (EPA ICR No. 574). This action does not impose any burden requiring additional OMB approval. If an entity were to submit a SNUN to the Agency, the annual burden is estimated to average between 30 and 170 hours per response. This burden estimate includes the time needed to review instructions, search existing data sources, gather and maintain the data needed, and complete, review, and submit the required SNUN. Send any comments about the accuracy of the burden estimate, and any suggested methods for minimizing respondent burden, including through the use of automated collection techniques, to the Director, Collection Strategies Division, Office of Environmental Information (2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001. Please remember to include the OMB control number in any correspondence, but do not submit any completed forms to this address. C. Regulatory Flexibility Act (RFA) On February 18, 2012, EPA certified pursuant to RFA section 605(b) (5 U.S.C. 601 et seq.), that promulgation of a SNUR does not have a significant economic impact on a substantial number of small entities where the following are true: 1. A significant number of SNUNs would not be submitted by small entities in response to the SNUR. 2. The SNUR submitted by any small entity would not cost significantly more than $8,300. A copy of that certification is available in the docket for this action. This action is within the scope of the February 18, 2012 certification. Based on the Economic Analysis discussed in Unit XI. and EPA's experience promulgating SNURs (discussed in the certification), EPA believes that the following are true: A significant number of SNUNs would not be submitted by small entities in response to the SNUR. Submission of the SNUN would not cost any small entity significantly more than $8,300. Therefore, the promulgation of the SNUR would not have a significant economic impact on a substantial number of small entities. D. Unfunded Mandates Reform Act (UMRA) Based on EPA's experience with proposing and finalizing SNURs, State, local, and Tribal governments have not been impacted by these rulemakings, and EPA does not have any reasons to believe that any State, local, or Tribal government will be impacted by this action. As such, EPA has determined that this action does not impose any enforceable duty, contain any unfunded mandate, or otherwise have any effect on small governments subject to the requirements of UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.). E. Executive Order 13132 This action will not have a substantial direct effect on States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132, entitled ``Federalism'' (64 FR 43255, August 10, 1999). F. Executive Order 13175 This action does not have Tribal implications because it is not expected to have substantial direct effects on Indian Tribes. This action does not significantly nor uniquely affect the communities of Indian Tribal governments, nor does it involve or impose any requirements that affect Indian Tribes. Accordingly, the requirements of Executive Order 13175, entitled ``Consultation and Coordination with Indian Tribal Governments'' (65 FR 67249, November 9, 2000), do not apply to this action. G. Executive Order 13045 This action is not subject to Executive Order 13045, entitled ``Protection of Children from Environmental Health Risks and Safety Risks'' (62 FR 19885, April 23, 1997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this action does not address environmental health or safety risks disproportionately affecting children. H. Executive Order 13211 This action is not subject to Executive Order 13211, entitled ``Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use'' (66 FR 28355, May 22, 2001), because this action is not expected to affect energy supply, distribution, or use and because this action is not a significant regulatory action under Executive Order 12866. I. National Technology Transfer and Advancement Act (NTTAA) In addition, since this action does not involve any technical standards, NTTAA section 12(d) (15 U.S.C. 272 note), does not apply to this action. J. Executive Order 12898 This action does not entail special considerations of environmental justice related issues as delineated by Executive Order 12898, entitled ``Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations'' (59 FR 7629, February 16, 1994). XIII. Congressional Review Act Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.), EPA will submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of the rule in the Federal Register. This action is not a ``major rule'' as defined by 5 U.S.C. 804(2). List of Subjects 40 CFR Part 9 Environmental protection, Reporting and recordkeeping requirements. 40 CFR Part 721 Environmental protection, Chemicals, Hazardous substances, Reporting and recordkeeping requirements. Dated: April 5, 2017. Maria J. Doa, Director, Chemical Control Division, Office of Pollution Prevention and Toxics. Therefore, 40 CFR parts 9 and 721 are amended as follows: PART 9--[AMENDED] 0 1. The authority citation for part 9 continues to read as follows: Authority: 7 U.S.C. 135 et seq., 136-136y; 15 U.S.C. 2001, 2003, 2005, 2006, 2601-2671; 21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33 U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 1321, 1326, 1330, 1342, 1344, 1345 (d) and (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR, [[Page 44092]] 1971-1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f, 300g, 300g-1, 300g-2, 300g-3, 300g-4, 300g-5, 300g-6, 300j-1, 300j-2, 300j-3, 300j-4, 300j-9, 1857 et seq., 6901-6992k, 7401-7671q, 7542, 9601-9657, 11023, 11048. 0 2. In Sec. 9.1, add the following sections in numerical order under the undesignated center heading ``Significant New Uses of Chemical Substances'' to read as follows: Sec. 9.1 OMB approvals under the Paperwork Reduction Act. * * * * * ------------------------------------------------------------------------ OMB control 40 CFR citation No. ------------------------------------------------------------------------ ------------------------------------------------------------------------ * * * * * Significant New Uses of Chemical Substances............................. * * * * * 721.10961............................................... 2070-0012 721.10962............................................... 2070-0012 721.10963............................................... 2070-0012 721.10964............................................... 2070-0012 721.10965............................................... 2070-0012 721.10966............................................... 2070-0012 721.10967............................................... 2070-0012 721.10968............................................... 2070-0012 721.10969............................................... 2070-0012 721.10970............................................... 2070-0012 721.10971............................................... 2070-0012 721.10972............................................... 2070-0012 721.10973............................................... 2070-0012 721.10974............................................... 2070-0012 721.10975............................................... 2070-0012 721.10976............................................... 2070-0012 721.10977............................................... 2070-0012 721.10978............................................... 2070-0012 721.10979............................................... 2070-0012 721.10980............................................... 2070-0012 721.10981............................................... 2070-0012 721.10982............................................... 2070-0012 721.10983............................................... 2070-0012 721.10984............................................... 2070-0012 721.10985............................................... 2070-0012 721.10986............................................... 2070-0012 721.10987............................................... 2070-0012 721.10988............................................... 2070-0012 721.10989............................................... 2070-0012 721.10990............................................... 2070-0012 721.10991............................................... 2070-0012 721.10992............................................... 2070-0012 721.10993............................................... 2070-0012 721.10994............................................... 2070-0012 721.10995............................................... 2070-0012 * * * * * ------------------------------------------------------------------------ * * * * * PART 721--[AMENDED] 0 3. The authority citation for part 721 continues to read as follows: Authority: 15 U.S.C. 2604, 2607, and 2625(c). 0 4. Add Sec. 721.10961 to subpart E to read as follows: Sec. 721.10961 Ethylene glycol ester of an aromatic substituted propenoic acid (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as ethylene glycol ester of an aromatic substituted propenoic acid (PMN P- 05-436) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=10). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 5. Add Sec. 721.10962 to subpart E to read as follows: Sec. 721.10962 Phosphoric acid, metal salt (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as phosphoric acid, metal salt (PMN P-10-504) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j) and (s) (100,000 kilograms). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 6. Add Sec. 721.10963 to subpart E to read as follows: Sec. 721.10963 Alkanoic acid, tetramethylheteromonocycle ester (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as alkanoic acid, tetramethylheteromonocycle ester (PMN P-13-289) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=2). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 7. Add Sec. 721.10964 to subpart E to read as follows: Sec. 721.10964 Polyether polyester urethane phosphate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as polyether polyester urethane phosphate (PMN P-13-908) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(f), (j) and (s) (1,000 kilograms). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. [[Page 44093]] 0 8. Add Sec. 14;721.10965 to subpart E to read as follows: Sec. 721.10965 Propanamide, 2-hydroxy-N,N-dimethyl-. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as propanamide, 2- hydroxy-N,N-dimethyl- (PMN P-14-129, CAS No. 35123-06-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(2)(i), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j) and (o). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 9. Add Sec. 14;721.10966 to subpart E to read as follows: Sec. 721.10966 1-Propene, 2-bromo-3,3,3-trifluoro-. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as 1-propene, 2-bromo- 3,3,3-trifluoro- (PMN P-14-260, CAS No. 1514-82-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this rule do not apply to quantities of the PMN substance after they have been charged into a fire extinguisher or fire extinguishing system. (2) The significant new uses are: (i) Protection in the workplace. (A) Requirements as specified in Sec. 721.63(a)(1), (a)(3), (a)(4), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1.0 percent), and (c). When determining which persons are reasonably likely to be exposed as required for Sec. 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. The following National Institute for Occupational Safety and Health (NIOSH)-certified respirator with an Applied Protection Factor (APF) of at least 10 meet the requirements of Sec. 721.63(a)(4): (1) NIOSH-certified air-purifying half mask respirator equipped with a gas/vapor (organic vapor) cartridge. (2) NIOSH-certified powered air-purifying respirator with a hood or helmet and with a gas/vapor (organic vapor) cartridge. (3) NIOSH-certified negative pressure (demand) supplied-air respirator with a half-mask. (4) NIOSH-certified continuous flow supplied-air respirator with a loose fitting facepiece, hood, or helmet. (5) NIOSH-certified negative pressure (demand) self-contained breathing apparatus (SCBA) with a half-mask. (B) As an alternative to the respirator requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA section 5(e) consent order for this substance. The NCEL is 1.0 parts per million (ppm) as an 8-hour time weighted average. Persons who wish to pursue NCELs as an alternative to Sec. 721.63 respirator requirements may request to do so under Sec. 721.30. Persons whose Sec. 721.30 requests to use the NCELs approach are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA section 5(e) consent order. (ii) Hazard communication program. Requirements as specified in Sec. 721.72(a) through (e) (concentration set at 1.0 percent), (f), (g)(1) (cardiac sensitization and reproductive effects), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). (iii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(c), (f), and (k) (A significant new use is any use other than as either a total flooding agent in unoccupied spaces, specifically engine nacelles and auxiliary power units (APUs) in aircraft; or as a streaming fire extinguishing agent for use only in handheld extinguishers in aircraft). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 10. Add Sec. 14;721.10967 to subpart E to read as follows: Sec. 721.10967 Pyrolysis oil product (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as pyrolysis oil product (PMN P-14-759) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. (A) Requirements as specified in Sec. 721.63(a)(1), (a)(3), (a)(4), (a)(6) (particulate and gas/vapor), (b) (concentration set at 0.1 percent), and (c). When determining which persons are reasonably likely to be exposed as required for Sec. 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. The following National Institute for Occupational Safety and Health (NIOSH)-certified respirator with an Applied Protection Factor (APF) of at least 10 meet the requirements of Sec. 721.63(a)(4): (1) NIOSH-certified air-purifying half mask respirator equipped with an organic vapor cartridge. (2) NIOSH-certified powered air-purifying respirator with a hood or helmet and with an organic vapor cartridge. (3) NIOSH-certified negative pressure (demand) supplied-air respirator with a half-mask. (4) NIOSH-certified continuous flow supplied-air respirator with a loose fitting facepiece, hood, or helmet. (5) NIOSH-certified negative pressure (demand) self-contained breathing apparatus (SCBA) with a half-mask. (B) As an alternative to the respirator requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA section 5(e) consent order for this substance. The NCEL is 0.5 parts per million (ppm) as an 8-hour time weighted average. Persons who wish to pursue NCELs as an alternative to Sec. 721.63 respirator requirements may request to do so under Sec. 721.30. Persons whose Sec. 721.30 requests to use the NCELs approach are approved by EPA will be required to follow NCELs provisions comparable to those [[Page 44094]] contained in the corresponding TSCA section 5(e) consent order. (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(k). (iii) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=20). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e), (i) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 11. Add Sec. 14;721.10968 to subpart E to read as follows: Sec. 721.10968 1-Octanamine, 7 (or 8)-(aminomethyl)-. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as 1-octanamine, 7 (or 8)-(aminomethyl)- (PMN P-15-279, CAS No. 1613320-81-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=123). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 12. Add Sec. 721.10969 to subpart E to read as follows: Sec. 721.10969 Substituted alkanolamine ether (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as substituted alkanolamine ether (PMN P-15-409) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Hazard communication program. A significant new use of the substance is any manner or method of manufacture or processing associated with any use of the substance without providing risk notification as follows: (A) If as a result of the test data required under TSCA section 5(e) consent order for the substance, the employer becomes aware that the substances may present a risk of injury to human health or the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in Sec. 721.72(c) within 90 days from the time the employer becomes aware of the new information. If the substance is not being manufactured, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. (B) The employer must ensure that persons who will receive the PMN substance from the employer, or who have received the PMN substance from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information. (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(q). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c), (h) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 13. Add Sec. 721.10970 to subpart E to read as follows: Sec. 721.10970 Butanedioic acid, alkyl amine, dimethylbutyl ester (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as butanedioic acid, alkyl amine, dimethylbutyl ester (PMN P-15-583) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this rule do not apply to quantities of the PMN substance after they have been added to engine oil. (i) Hazard communication program. A significant new use of the substance is any manner or method of manufacture or processing associated with any use of the substance without providing risk notification as follows: (A) If as a result of the test data required under TSCA section 5(e) consent order for the substance, the employer becomes aware that the substances may present a risk of injury to human health or the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in Sec. 721.72(c) within 90 days from the time the employer becomes aware of the new information. If the substance is not being manufactured, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. (B) The employer must ensure that persons who will receive the PMN substance from the employer, or who have received the PMN substance from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information. (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(q). (iii) Release to water. Requirements as specified in Sec. 721.90(a)(1), (b)(1), and (c)(1). (2) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c), (h), (i) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 14. Add Sec. 721.10971 to subpart E to read as follows: [[Page 44095]] Sec. 721.10971 Carbon nanotube (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as carbon nanotube (PMN P-15-672) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), (a)(4), (a)(6) (particulate), and (c). When determining which persons are reasonably likely to be exposed as required for Sec. 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. A National Institute for Occupational Safety and Health (NIOSH)-certified respirators with an N-100, P-100, or R-100 cartridge meet the requirements of Sec. 721.63(a)(4). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80. It is a significant new use to process or use the chemical substance other than as an aqueous slurry, wet form, or a contained dry form as described in the PMN. (iii) Disposal. Requirements as specified in Sec. 721.85(a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). (iv) Release to water. Requirements as specified in Sec. 721.90(a)(1), (b)(1), and (c)(1). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) through (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 0 15. Add Sec. 721.10972 to subpart E to read as follows: Sec. 721.10972 Metal salt of mineral acid, reaction products with alumina, aluminum hydroxide, aluminum hydroxide oxide (Al(OH)O), silica, titanium oxide (TiO2) and 3-(triethoxysilyl)-1-propanamine (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as metal salt of mineral acid, reaction products with alumina, aluminum hydroxide, aluminum hydroxide oxide (Al(OH)O), silica, titanium oxide (TiO2) and 3-(triethoxysilyl)-1-propanamine (PMN P-15-678) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 16. Add Sec. 721.10973 to subpart E to read as follows: Sec. 721.10973 Halogenated bisphenol A, polymer with epichlorohydrin, alkenoate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as halogenated bisphenol A, polymer with epichlorohydrin, alkenoate (PMN P-15-766) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j), (o) and (s) (10,000 kilograms). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 17. Add Sec. 721.10974 to subpart E to read as follows: Sec. 721.10974 Halogenated bisphenol A, polymer with bisphenol A diglycidyl ether and epoxidized phenol-formaldehyde resin, alkenoate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substances identified generically as halogenated bisphenol A, polymer with bisphenol A diglycidyl ether and epoxidized phenol-formaldehyde resin, alkenoate (PMN P-15-767) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j), (o) and (s) (10,000 kilograms). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 18. Add Sec. 721.10975 to subpart E to read as follows: Sec. 721.10975 Silicon, tris[dialkyl phenyl]-dialkyl-dioxoalkane- naphthalene disulfonate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as silicon, tris[dialkyl phenyl]-dialkyl-dioxoalkane-naphthalene disulfonate (PMN P-16-14) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j). The significant new use is use other than as described in PMN-16-14 where the surface water concentrations described in paragraph (a)(3)(i) are exceeded. (ii) [Reserved] (3) The significant new uses for any use other than as described in PMN-16-14: [[Page 44096]] (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=6). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 19. Add Sec. 721.10976 to subpart E to read as follows: Sec. 721.10976 Tar acids fraction (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as tar acids fraction (PMN P-16-40) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=45). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 20. Add Sec. 721.10977 to subpart E to read as follows: Sec. 721.10977 Dialkyl fattyalkylamino propanamide alkylamine (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as dialkyl fattyalkylamino propanamide alkylamine (PMN P-16-59) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 21. Add Sec. 721.10978 to subpart E to read as follows: Sec. 721.10978 Fattyalkylaminopropanoate ester (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as fattyalkylaminopropanoate ester (PMN P-16-60) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 22. Add Sec. 721.10979 to subpart E to read as follows: Sec. 721.10979 Boron sodium oxide (B5NaO8), labeled with boron-10. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as boron sodium oxide (B5NaO8), labeled with boron-10 (PMN P-16-70, CAS No. 200443-98-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80. A significant new use is any use of the substance other than as an emergency shutdown coolant in boiler water reactors. (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 23. Add Sec. 721.10980 to subpart E to read as follows: Sec. 721.10980 Perfluoropolyether modified organosilane (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as perfluoropolyether modified organosilane (PMN P-16-94) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(s) (500 kilograms). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 24. Add Sec. 721.10981 to subpart E to read as follows: Sec. 721.10981 Modified phenol-formaldehyde resin (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as modified phenol-formaldehyde resin (PMN P-16-95) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j). (ii) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=96). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c), (i), and (k) are [[Page 44097]] applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 25. Add Sec. 721.10982 to subpart E to read as follows: Sec. 721.10982 Disubstituted benzene alkanal (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as disubstituted benzene alkanal (PMN P-16-101) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(2)(i), (a)(3), (b) (concentration set at 1.0 percent), and (c). (ii) Industrial commercial, and consumer activities. Requirements as specified in Sec. 721.80(j). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 26. Add Sec. 721.10983 to subpart E to read as follows: Sec. 721.10983 Phthalic anhydride, polymer with alkylene glycol and alkanepolyol, acrylate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as phthalic anhydride, polymer with alkylene glycol and alkanepolyol, acrylate (PMN P-16-102) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 27. Add Sec. 721.10984 to subpart E to read as follows: Sec. 721.10984 2-Pyridinecarboxylic acid, 4,5-dichloro-6-(4-chloro- 2-fluoro-3-methoxyphenyl)-. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as 2- pyridinecarboxylic acid, 4,5-dichloro-6-(4-chloro-2-fluoro-3- methoxyphenyl)- (PMN P-16-104, CAS No. 1546765-39-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(g). (ii) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=8). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 28. Add Sec. 721.10985 to subpart E to read as follows: Sec. 721.10985 Dialkylamino alkylamide inner salt (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substances identified generically as dialkylamino alkylamide inner salt (PMNs P-16-136, P-16-139 and P-16- 140) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of these substances. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 29. Add Sec. 721.10986 to subpart E to read as follows: Sec. 721.10986 Nanocarbon (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as nanocarbon (PMN P-16-170) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this rule do not apply when the PMN substance is incorporated into the composite material allowed by the section 5(e) consent order. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), (a)(4), (a)(6) (particulate), and (c). When determining which persons are reasonably likely to be exposed as required for Sec. 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. A National Institute for Occupational Safety and Health (NIOSH)-certified respirators with an N-100, P-100, or R-100 cartridge meet the requirements of Sec. 721.63(a)(4). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(k) and (q). A significant new use is any use involving an application method that generates a vapor, mist or aerosol. (iii) Disposal. Requirements as specified in Sec. 721.85(a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). (iv) Release to water. Requirements as specified in Sec. 721.90(a)(1), (b)(1), and (c)(1). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) through (k) are applicable to manufacturers and processors of this substance. [[Page 44098]] (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 0 30. Add Sec. 721.10987 to subpart E to read as follows: Sec. 721.10987 Barium molybdenum niobium tantalum tellurium vanadium zinc oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as barium molybdenum niobium tantalum tellurium vanadium zinc oxide (PMN P-16-177, CAS No. 1440529-21-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(4), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 1.0 percent) and (c). When determining which persons are reasonably likely to be exposed as required for Sec. 721.63(a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. The following National Institute for Occupational Safety and Health (NIOSH)-certified respirators with an assigned protection factor (APF) of at least 10 meet the requirements of Sec. 721.63(a)(4). (ii) Industrial, commercial, and consumer activities. Requirements as specified in 721.80(f) and (j). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (d) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 0 31. Add Sec. 721.10988 to subpart E to read as follows: Sec. 721.10988 Alkanoic acids, esters with alkanetriol (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as alkanoic acids, esters with alkanetriol (PMN P-16-179) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 32. Add Sec. 721.10989 to subpart E to read as follows: Sec. 721.10989 Manganese, tris[.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical A). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as manganese, tris[.mu.-(2-ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7- trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (PMN P- 16-182, chemical A; CAS No. 2020407-62-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(f) and (j) (a significant new use is any manufacture at a concentration of greater than 10% of the PMN substance in any formulation). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 33. Add Sec. 721.10990 to subpart E to read as follows: Sec. 721.10990 Manganese, [.mu.- (acetato-.kappa.O:.kappa.O')]bis[.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical B). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as manganese, [.mu.- (acetato-.kappa.O:.kappa.O')]bis[.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (PMN P-16-182, chemical B; CAS No. 2020407-63-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(f) and (j) (a significant new use is any manufacture at a concentration of greater than 10% of the PMN substance in any formulation). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 34. Add Sec. 721.10991 to subpart E to read as follows: Sec. 721.10991 Manganese, bis[.mu.- (acetato-.kappa.O:.kappa.O')][.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical C). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as manganese, bis[.mu.-(acetato-.kappa.O:.kappa.O')][.mu.-(2- ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H- 1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (PMN P-16-182, chemical C; CAS No. 2020407-64-9) is subject to reporting [[Page 44099]] under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(f) and (j) (a significant new use is any manufacture at a concentration of greater than 10% of the PMN substance in any formulation). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 35. Add Sec. 721.10992 to subpart E to read as follows: Sec. 721.10992 Manganese, tris[.mu.- (acetato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7- triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical D). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as manganese, tris[.mu.-(acetato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl- 1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (PMN P-16-182, chemical D; CAS No. 2020407-65-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(f) and (j) (a significant new use is any manufacture at a concentration of greater than 10% of the PMN substance in any formulation). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (e) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 36. Add Sec. 721.10993 to subpart E to read as follows: Sec. 721.10993 Aryl polyolefin (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as aryl polyolefin (PMN P-16-190) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Protection in the workplace. Requirements as specified in Sec. 721.63(a)(1), (a)(3), and (b) (concentration set at 1.0 percent). (ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(j). (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (d) and (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. (3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 0 37. Add Sec. 721.10994 to subpart E to read as follows: Sec. 721.10994 Melamine nitrate (generic). (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as melamine nitrate (PMN P-16-260) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=14). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. 0 38. Add Sec. 721.10995 to subpart E to read as follows: Sec. 721.10995 Lecithins, soya, hydrogenated. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as lecithins, soya, hydrogenated (PMN P-16-272, CAS No. 308068-11-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i) Release to water. Requirements as specified in Sec. 721.90(a)(4), (b)(4), and (c)(4) (N=1). (ii) [Reserved] (b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125(a) through (c) and (k) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. [FR Doc. 2017-20158 Filed 9-20-17; 8:45 am] BILLING CODE 6560-50-P
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44079
Sector New Orleans (COTP) or review of the notice, made an SUPPLEMENTARY INFORMATION:
designated representative. appropriate determination on the notice,
(2) Vessels requiring entry into this I. General Information
and take such actions as are required
safety zone must request permission with that determination. A. Does this action apply to me?
from the COTP or a designated DATES: This rule is effective on
representative. They may be contacted You may be potentially affected by
November 20, 2017. For purposes of
on VHF–FM Channel 16 or 67. this action if you manufacture, process,
judicial review, this rule shall be
(3) Persons and vessels permitted to or use the chemical substances
promulgated at 1 p.m. (e.s.t.) on October
enter this safety zone must transit at contained in this rule. The following list
5, 2017.
their slowest safe speed and comply Written adverse or critical comments, of North American Industrial
with all lawful directions issued by the or notice of intent to submit adverse or Classification System (NAICS) codes is
COTP or the designated representative. critical comments, on one or more of not intended to be exhaustive, but rather
(e) Information broadcasts. The COTP these SNURs must be received on or provides a guide to help readers
or a designated representative will before October 23, 2017 (see Unit VI. of determine whether this document
inform the public through Broadcast the SUPPLEMENTARY INFORMATION). If EPA applies to them. Potentially affected
Notices to Mariners of any changes in receives written adverse or critical entities may include:
the planned schedule. comments, or notice of intent to submit • Manufacturers or processors of one
Dated: September 15, 2017. adverse or critical comments, on one or or more subject chemical substances
Wayne R. Arguin, more of these SNURs before October 23, (NAICS codes 325 and 324110), e.g.,
Captain, U.S. Coast Guard, Captain of the 2017, EPA will withdraw the relevant chemical manufacturing and petroleum
Port New Orleans. sections of this direct final rule before refineries.
[FR Doc. 2017–20109 Filed 9–20–17; 8:45 am] its effective date. This action may also affect certain
BILLING CODE 9110–04–P
For additional information on related entities through pre-existing import
reporting requirement dates, see Units certification and export notification
I.A., VI., and VII. of the SUPPLEMENTARY rules under TSCA. Chemical importers
INFORMATION. are subject to the TSCA section 13 (15
ENVIRONMENTAL PROTECTION
AGENCY ADDRESSES: Submit your comments, U.S.C. 2612) import certification
identified by docket identification (ID) requirements promulgated at 19 CFR
40 CFR Parts 9 and 721 number EPA–HQ–OPPT–2016–0331, by 12.118 through 12.127 and 19 CFR
one of the following methods: 127.28. Chemical importers must certify
[EPA–HQ–OPPT–2016–0331; FRL–9959–81] • Federal eRulemaking Portal: http:// that the shipment of the chemical
RIN 2070–AB27 www.regulations.gov. Follow the online substance complies with all applicable
instructions for submitting comments. rules and orders under TSCA. Importers
Significant New Use Rules on Certain Do not submit electronically any of chemicals subject to these SNURs
Chemical Substances information you consider to be must certify their compliance with the
AGENCY: Environmental Protection Confidential Business Information (CBI) SNUR requirements. The EPA policy in
Agency (EPA). or other information whose disclosure is support of import certification appears
restricted by statute. at 40 CFR part 707, subpart B. In
ACTION: Direct final rule.
• Mail: Document Control Office addition, any persons who export or
SUMMARY: EPA is promulgating (7407M), Office of Pollution Prevention intend to export a chemical substance
significant new use rules (SNURs) under and Toxics (OPPT), Environmental that is the subject of this rule on or after
the Toxic Substances Control Act Protection Agency, 1200 Pennsylvania October 23, 2017 are subject to the
(TSCA) for 37 chemical substances Ave. NW., Washington, DC 20460–0001. export notification provisions of TSCA
which were the subject of • Hand Delivery: To make special section 12(b) (15 U.S.C. 2611(b)) (see
premanufacture notices (PMNs). The arrangements for hand delivery or § 721.20), and must comply with the
applicable review periods for the PMNs delivery of boxed information, please export notification requirements in 40
submitted for these 37 chemical follow the instructions at http:// CFR part 707, subpart D.
substances all ended prior to June 22, www.epa.gov/dockets/contacts.html.
Additional instructions on commenting B. What should I consider as I prepare
2016 (i.e., the date on which President my comments for EPA?
Obama signed into law the Frank R. or visiting the docket, along with more
Lautenberg Chemical Safety for the 21st information about dockets generally, is 1. Submitting CBI. Do not submit this
Century Act which amends TSCA). Six available at http://www.epa.gov/ information to EPA through
of these chemical substances are subject dockets. regulations.gov or email. Clearly mark
to TSCA section 5(e) consent orders FOR FURTHER INFORMATION CONTACT: For the part or all of the information that
issued by EPA. This action requires technical information contact: Kenneth you claim to be CBI. For CBI
persons who intend to manufacture Moss, Chemical Control Division information in a disk or CD–ROM that
(defined by statute to include import) or (7405M), Office of Pollution Prevention you mail to EPA, mark the outside of the
process any of these 37 chemical and Toxics, Environmental Protection disk or CD–ROM as CBI and then
substances for an activity that is Agency, 1200 Pennsylvania Ave. NW. identify electronically within the disk or
designated as a significant new use by Washington, DC 20460–0001; telephone CD–ROM the specific information that
asabaliauskas on DSKBBXCHB2PROD with RULES
this rule to notify EPA at least 90 days number: (202) 564–9232; email address: is claimed as CBI. In addition to one
before commencing that activity. The moss.kenneth @epa.gov. complete version of the comment that
required notification initiates EPA’s For general information contact: The includes information claimed as CBI, a
evaluation of the intended use within TSCA–Hotline, ABVI–Goodwill, 422 copy of the comment that does not
the applicable review period. South Clinton Ave. Rochester, NY contain the information claimed as CBI
Manufacture and processing for the 14620; telephone number: (202) 554– must be submitted for inclusion in the
significant new use is unable to 1404; email address: TSCA-Hotline@ public docket. Information so marked
commence until EPA has conducted a epa.gov. will not be disclosed except in
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00027 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/1.svg)
![44084 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
Basis for TSCA section 5(e) consent substance is as an industrial paper combined repeated dose toxicity test
order: The PMN states that the generic additive. Based on SAR analysis of test (OECD Test Guideline 422) with the
(non-confidential) use of the PMN data on analogous respirable, poorly reproduction/developmental toxicity
substance will be in filtration media. soluble particulates, EPA identified screening test; a fish early-life stage
Based on test data on analogous concerns for lung toxicity if inhaled toxicity test (OCSPP Test Guideline
respirable, poorly soluble particulates based on lung overload. As described in 850.1400); a daphnid chronic toxicity
and carbon nanotubes, EPA identified the PMN, inhalation is expected to be test (OCSPP Test Guideline 850.1300);
concerns for pulmonary toxicity and minimal for this use. Therefore, EPA has and an algal toxicity test (OCSPP Test
oncogenicity. Based on test data for not determined that the proposed Guideline 850.4500) would help
other carbon nanotubes EPA identified manufacturing, processing, or use of the characterize the human health and
concerns for environmental toxicity. substance may present an unreasonable environmental effects of the PMN
The Order was issued under TSCA risk. EPA has determined, however, that substances.
sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), any use of the substance other than as CFR citations: 40 CFR 721.10973 (P–
based on a finding that the substance identified in the PMN may result in 15–766) and 40 CFR 721.10974 (P–15–
may present an unreasonable risk of serious health effects. Based on this 767).
injury to human health and the information, the PMN meets the concern
criteria at § 721.170(b)(3)(ii). PMN Number P–16–14
environment. To protect against these
risks, the consent order requires: Recommended testing: EPA has Chemical name: Silicon, tris[dialkyl
1. Use of personal protective determined that the results of a 90-day phenyl]-dialkyl-dioxoalkane-
equipment involving impervious gloves inhalation toxicity test (OPPTS Test naphthalene disulfonate (generic).
and protective clothing (where there is Guideline 870.3465) would help CAS number: Not available.
a potential for dermal exposure) and a characterize the human health effects of Basis for action: The PMN states that
NIOSH-certified respirator with N–100, the PMN substance. the generic (non-confidential) use of the
P–100, or R–100 cartridges (where there CFR citation: 40 CFR 721.10972. substance is as an ink additive. Based
is a potential for inhalation exposure). on test data on the PMN substance, as
PMN Numbers P–15–766 and P–15–767
2. Processing and use of the PMN well as SAR analysis of test data on
substance only for the use specified in Chemical names: Halogenated analogous diketones, EPA predicts
the consent order. bisphenol A, polymer with toxicity to aquatic organisms may occur
3. Processing and use of the PMN epichlorohydrin, alkenoate (generic) (P– at concentrations that exceed 6 ppb of
substance only as an aqueous slurry, 15–766) and Halogenated bisphenol A, the PMN substance in surface waters. As
wet form, or a contained dry form as polymer with bisphenol A diglycidyl described in the PMN, releases of the
described in the PMN. ether and epoxidized phenol- substance during the use described in
4. No use of the PMN substance formaldehyde resin, alkenoate (generic) the PMN are not expected to result in
resulting in releases to surface waters (P–15–767). surface water concentrations that exceed
and disposal of the PMN substance only CAS numbers: Not available. 6 ppb. Therefore, EPA has not
by landfill or incineration. Basis for action: The PMNs state that determined that the proposed
The SNUR would designate as a the generic (non-confidential) use of the manufacturing, processing, or use of the
‘‘significant new use’’ the absence of substances will be as resins for flame substance for the use described in the
these protective measures. retardant polyester. Based on test data PMN may present an unreasonable risk.
Recommended testing: EPA has on the confidential impurity of the PMN EPA has determined, however, that any
determined that a two-year inhalation substance, EPA identified concerns for use of the substance resulting in surface
bioassay (OPPTS 870.4200); a fish early- chronic toxicity effects to workers and water concentrations exceeding 6 ppb
life stage toxicity test (OCSPP Test the general population exposed to the may cause significant adverse
Guideline 850.1400); a daphnid chronic PMN substances. Further, based on the environmental effects. Based on this
toxicity test (OCSPP Test Guideline confidential impurity, EPA predicts information, the PMN substance meets
850.1300); and an algal toxicity test toxicity to aquatic organisms may occur the concern criteria at § 721.170(b)(4)(i)
(OCSPP Test Guideline 850.4500) would at concentrations that exceed 20 ppb of and (b)(4)(ii).
help characterize possible health and the impurity in surface waters. As Recommended testing: EPA has
environmental effects of the substance. described in the PMNs, EPA does not determined that the results of a ready
Although the Order does not require expect significant occupational biodegradability test (OECD Test
these tests, the Order’s restrictions on exposures, general population Guideline 301); a fish early-life state
manufacture, processing, distribution in exposures, nor releases of the substance toxicity test (OCSPP Test Guideline
commerce, and disposal will remain in to result in surface water concentrations 850.1400); and a daphnid chronic
effect until the Order is modified or that exceed 20 ppb of the impurity in toxicity test (OCSPP Test Guideline
revoked by EPA based on submission of surface waters. Therefore, EPA has not 850.1300) would help characterize the
this or other relevant information. determined that the proposed environmental effects of the PMN
CFR citation: 40 CFR 721.10971. manufacturing, processing, or use of the substance.
substances may present an unreasonable CFR citation: 40 CFR 721.10975.
PMN Number P–15–678 risk. EPA has determined, however, that
Chemical name: Metal salt of mineral any consumer use, any use other than as PMN Number P–16–40
acid, reaction products with alumina, described in the PMNs, or any increase Chemical name: Tar acids fraction
asabaliauskas on DSKBBXCHB2PROD with RULES
aluminum hydroxide, aluminum in production volume over 10,000 kg/yr (generic).
hydroxide oxide (Al(OH)O), silica, may result in serious human health and CAS number: Not available.
titanium oxide (TiO2) and 3- significant adverse environmental Basis for action: The PMN states that
(triethoxysilyl)-1-propanamine effects. Based on this information, the the generic (non-confidential) use of the
(generic). PMN substances meet the concern substance is as a polymer. Based on test
CAS number: Not available. criteria at § 721.170(b)(5)(ii). data on the PMN substance, as well as
Basis for action: The PMN states that Recommended testing: EPA has SAR analysis of test data on analogous
the generic (non-confidential) use of the determined that the results of a phenols, EPA predicts toxicity to
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/6.svg)
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44087
predicts toxicity to aquatic organisms 4. Processing and use of the PMN manufacturing, processing, or use of the
may occur at concentrations that exceed substance only for the use specified in substance may present an unreasonable
1 ppb of the PMN substances in surface the consent order including no risk. EPA has determined, however, that
waters. As described in the PMNs, application method that generates a use of the substance without a National
releases of these substances are not vapor, mist or aerosol unless the Institute for Occupational Safety and
expected to result in surface water application method occurs in an Health (NIOSH)-certified respirators
concentrations that exceed 1 ppb. enclosed process. with an assigned protection factor (APF)
Therefore, EPA has not determined that 5. No use of the PMN substance of at least 10, where there is potential
the proposed manufacturing, resulting in releases to surface waters respiratory exposure, any use other than
processing, or use of the substances may and disposal of the PMN substance only in the PMN, or domestic manufacture
present an unreasonable risk. EPA has by landfill or incineration. may result in serious human health
determined, however, that any use of The SNUR would designate as a effects. Based on this information, the
the substances resulting in surface water ‘‘significant new use’’ the absence of PMN substance meets the concern
concentrations exceeding 1 ppb may these protective measures. criteria at § 721.170(b)(3)(ii).
cause significant adverse environmental Recommended testing: EPA has Recommended testing: EPA has
effects. Based on this information, the determined that the development of determined that the results of a 90-day
PMN substances meets the concern data on certain physical-chemical subchronic toxicity test (OPPTS Test
criteria at § 721.170(b)(4)(ii). properties, as well as certain human Guideline 870.3465) via the inhalation
Recommended testing: EPA has health and environmental toxicity route with a 60-day holding period
determined that the results of a fish testing would help characterize possible would help characterize the human
early-life stage toxicity test (OCSPP Test effects of the substance. The submitter health effects of the PMN substance.
Guideline 850.1400); a mysid chronic has agreed to provide a dustiness test CFR citation: 40 CFR 721.10987.
toxicity test (OCSPP Test Guideline (European Standard EU 15051) by six
months from commencement of PMN Number P–16–179
850.1350); and an algal toxicity test
(OCSPP Test Guideline 850.4500) would manufacture. In addition, the submitter Chemical name: Alkanoic acids,
help characterize the environmental has agreed not to exceed the esters with alkanetriol (generic).
effects of the PMN substances. Testing confidential production limit without CAS number: Not available.
should be conducted on PMN substance performing a 90-day inhalation toxicity Basis for action: The PMN states that
P–16–139. test (OPPTS Test Guideline 870.3465 or the generic (non-confidential) use of the
CFR citation: 40 CFR 721.10985. OECD Test Guideline 413) in rats with substance is as a grease. Based on SAR
a post-exposure observation period of analysis of test data on analogous esters,
PMN Number P–16–170 up to 9 months (including BALF EPA predicts toxicity to aquatic
Chemical name: Nanocarbon analysis, a determination of organisms may occur at concentrations
(generic). cardiovascular toxicity (clinically-based that exceed 1 ppb of the PMN substance
CAS number: Not available. blood/plasma protein analyses), and in surface waters. As described in the
Effective date of TSCA section 5(e) histopathology of the heart). Although PMN, releases of the substance are not
consent order: June 21, 2016. the order does not require a two-year expected to result in surface water
Basis for TSCA section 5(e) consent inhalation bioassay (OPPTS Test concentrations that exceed 1 ppb.
order: The PMN states that the Guideline 870.4200), a daphnid chronic Therefore, EPA has not determined that
substance will be used as an additive to toxicity test (OPPTS Test Guideline the proposed manufacturing,
composite materials. Based on test data 850.1300), a fish early-life stage toxicity processing, or use of the substance may
on analogous respirable, poorly soluble test (OCSPP Test Guideline 850.1400), present an unreasonable risk. EPA has
particulates and nanocarbon materials, or an algal toxicity test (OCSPP Test determined, however, that any use of
EPA identified concerns for pulmonary Guideline 850.4500), the Order’s the substance resulting in surface water
toxicity and oncogenicity. Based on test restrictions on manufacture, processing, concentrations exceeding 1 ppb may
data for other nanocarbon materials EPA distribution in commerce, and disposal cause significant adverse environmental
identified concerns for environmental will remain in effect until the Order is effects. Based on this information, the
toxicity. The Order was issued under modified or revoked by EPA based on PMN substance meets the concern
TSCA sections 5(e)(1)(A)(i) and submission of this or other relevant criteria at § 721.170(b)(4)(ii).
5(e)(1)(A)(ii)(I), based on a finding that information. Recommended testing: EPA has
the substance may present an CFR citation: 40 CFR 721.10986. determined that the results of a fish
unreasonable risk of injury to human early-life stage toxicity test (OCSPP Test
health and the environment. To protect PMN Number P–16–177 Guideline 850.1400); a daphnid chronic
against these risks, the consent order Chemical name: Barium molybdenum toxicity test (OCSPP Test Guideline
requires: niobium tantalum tellurium vanadium 850.1300); and an algal toxicity test
1. Use of personal protective zinc oxide. (OCSPP Test Guideline 850.4500) would
equipment involving impervious gloves CAS number: 1440529–21–4. help characterize the environmental
and protective clothing (where there is Basis for action: The PMN states that effects of the PMN substance.
a potential for dermal exposure) and a the generic (non-confidential) use of the CFR citation: 40 CFR 721.10988.
NIOSH-certified respirator with N–100, substance is as a glass coating. Based on
SAR analysis of test data on the PMN Number P–16–182
P–100, or R–100 cartridges (where there
asabaliauskas on DSKBBXCHB2PROD with RULES
is a potential for inhalation exposure). analogous respirable, poorly soluble Chemical names: Manganese,
2. Submission of a dustiness test particulates, EPA identified concerns for tris[.mu.-(2-ethylhexanoato-
within six months of notice of lung effects to workers exposed to the .kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
commencement. PMN substance. As described in the trimethyl-1H-1,4,7-triazonine-
3. Submission of a 90-day chronic PMN, worker exposure will be minimal .kappa.N1,.kappa.N4,.kappa.N7)di- (P–
inhalation study prior to exceeding the due to the use of adequate respiratory 16–182, chemical A); Manganese, [.mu.-
confidential production volume limit protection. Therefore, EPA has not (acetato-.kappa.O:.kappa.O’)]bis[.mu.-(2-
specified in the consent order. determined that the proposed ethylhexanoato-
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/9.svg)
![44088 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
.kappa.O:.kappa.O’)]bis(octahydro-1,4,7- 422) would help characterize the human PMN may present an unreasonable risk.
trimethyl-1H-1,4,7-triazonine- health effects of the PMN substances. EPA has determined, however, that any
.kappa.N1,.kappa.N4,.kappa.N7)di- (P– CFR citations: 40 CFR 721.10989 (P– use of the substance resulting in surface
16–182, chemical B); Manganese, 16–182, chemical A), 40 CFR 721.10990 water concentrations exceeding 14 ppb
bis[.mu.-(acetato- (P–16–182, chemical B), 40 CFR may cause significant adverse
.kappa.O:.kappa.O’)][.mu.-(2- 721.10991 (P–16–182, chemical C), and environmental effects. Based on this
ethylhexanoato- 40 CFR 721.10992 (P–16–182, chemical information, the PMN substance meets
.kappa.O:.kappa.O’)]bis(octahydro-1,4,7- D). the concern criteria at § 721.170(b)(4)(i)
trimethyl-1H-1,4,7-triazonine- PMN Number P–16–190 and (b)(4)(ii).
.kappa.N1,.kappa.N4,.kappa.N7)di- (P–
Chemical name: Aryl polyolefin Recommended testing: EPA has
16–182, chemical C); and Manganese,
(generic). determined that the results of a fish
tris[.mu.-(acetato-
CAS number: Not available. early-life stage toxicity test (OCSPP Test
.kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
Basis for action: The PMN states that Guideline 850.1400) and a daphnid
trimethyl-1H-1,4,7-triazonine-
the generic (non-confidential) use of the chronic toxicity test (OCSPP Test
.kappa.N1,.kappa.N4,.kappa.N7)di- (P–
16–182, chemical D). substance will be as a lubricant. Based Guideline 850.1300) would help
on analogy to C10–13 alkyl derivatives characterize the environmental effects of
CAS numbers: 2020407–62–7 (P–16–
of benzene, EPA identified concerns for the PMN substance.
182, chemical A); 2020407–63–8 (P–16–
reproductive and developmental CFR citation: 40 CFR 721.10994.
182, chemical B); 2020407–64–9 (P–16–
toxicity to workers exposed to the PMN
182, chemical C); and 2020407–65–0 (P– PMN Number P–16–272
substance based on exposure to the
16–182, chemical D).
PMN substance via dermal exposure. As
Basis for action: The PMN states that Chemical name: Lecithins, soya,
described in the PMN, exposure is
the generic (non-confidential) use of the hydrogenated.
expected to be minimal due to use of
substances will be as resins. Based on CAS number: 308068–11–3.
adequate dermal personal protection
SAR analysis of test data on analogous
equipment. Therefore, EPA has not Basis for action: The PMN states that
compounds, EPA identified concerns for
determined that the proposed the generic (non-confidential) use of the
systemic effects to the thyroid and
manufacturing, processing, or use of the substance is an ingredient in a
pituitary gland, liver toxicity,
substance may present an unreasonable formulated product. Based on SAR
developmental and reproductive
risk. EPA has determined, however, that analysis of test data on analogous
toxicity, and mutagenicity. There are
use of the substance other than as amphoteric surfactants, EPA predicts
also concerns for immunotoxicity,
described in the PMN, or any use toxicity to aquatic organisms may occur
reproductive and developmental
without the use of dermal protection at concentrations that exceed 1 ppb of
toxicity, neurotoxicity, blood effects,
where there is a potential for dermal the PMN substance in surface waters. As
and kidney toxicity, and uncertain
exposures may cause serious human described in the PMN, releases of the
concerns for asthma and oncogenicity,
health effects. Based on this
based on manganese, and concerns for substance during the use described in
information, the PMN substance meets
developmental toxicity for branched the PMN are not expected to result in
the concern criteria at 40 CFR
acid hydrolysis products, by analogy to surface water concentrations that exceed
721.170(b)(3)(ii).
valproic acid and other acids that are Recommended testing: EPA has 1 ppb. Therefore, EPA has not
branched on the carbon adjacent to the determined that the results of a two- determined that the proposed
acid group, all based on exposure to the generation reproduction toxicity test manufacturing, processing, or use of the
PMN substances via inhalation or (OECD Test Guideline 416) would help substance for the use described in the
dermal exposure. As described in the characterize the human health effects of PMN may present an unreasonable risk.
PMN, exposure is expected to be the PMN substance. EPA has determined, however, that any
minimal due to negligible inhalation CFR citation: 40 CFR 721.10993. use of the substance resulting in surface
exposures and use of adequate dermal water concentrations exceeding 1 ppb
personal protection equipment. PMN Number P–16–260 may cause significant adverse
Therefore, EPA has not determined that Chemical name: Melamine nitrate environmental effects. Based on this
the proposed manufacturing, (generic). information, the PMN substance meets
processing, or use of the substances may CAS number: Not available. the concern criteria at
present an unreasonable risk. EPA has Basis for action: The PMN states that § 721.170(b)(4)(ii).
determined, however, that any domestic the generic (non-confidential) use of the
manufacture; any manufacture of the Recommended testing: EPA has
substance is as a gas generant for
PMN substances at a concentration determined that the results of a fish
automobile air bag inflators. Based on
greater than 10% in any formulation; or acute toxicity test, freshwater and
test data on the PMN substance, as well
any use of the PMN substances without as SAR analysis of test data on marine (OPPTS Test Guideline
the use of chemical impervious gloves, analogous melamines, EPA predicts 850.1075); an aquatic invertebrate acute
where there is a potential for dermal toxicity to aquatic organisms may occur toxicity test, freshwater daphnids
exposures may result in serious human at concentrations that exceed 14 ppb of (OCSPP Test Guideline 850.1010); an
health effects. Based on this the PMN substance in surface waters. As algal toxicity test (OCSPP Test
asabaliauskas on DSKBBXCHB2PROD with RULES
information, the PMN substances meet described in the PMN, releases of the Guideline 850.4500); a fish early-life
the concern criteria at 40 CFR substance during the use described in stage toxicity test (OCSPP Test
721.170(b)(3)(ii). the PMN are not expected to result in Guideline 850.1400); and a daphnid
Recommended testing: EPA has surface water concentrations that exceed chronic toxicity test (OCSPP Test
determined that the results of a 14 ppb. Therefore, EPA has not Guideline 850.1300) would help
combined repeated dose toxicity determined that the proposed characterize the environmental effects of
reproduction/development toxicity manufacturing, processing, or use of the the PMN substance.
screening test (OECD Test Guideline substance for the use described in the CFR citation: 40 CFR 721.10995.
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00036 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/10.svg)
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44091
requirements contained in this action. certification), EPA believes that the H. Executive Order 13211
This listing of the OMB control numbers following are true: This action is not subject to Executive
and their subsequent codification in the • A significant number of SNUNs Order 13211, entitled ‘‘Actions
CFR satisfies the display requirements would not be submitted by small Concerning Regulations That
of PRA and OMB’s implementing entities in response to the SNUR. Significantly Affect Energy Supply,
regulations at 5 CFR part 1320. This • Submission of the SNUN would not
Distribution, or Use’’ (66 FR 28355, May
Information Collection Request (ICR) cost any small entity significantly more
22, 2001), because this action is not
was previously subject to public notice than $8,300.
expected to affect energy supply,
and comment prior to OMB approval, Therefore, the promulgation of the
distribution, or use and because this
and given the technical nature of the SNUR would not have a significant
action is not a significant regulatory
table, EPA finds that further notice and economic impact on a substantial
action under Executive Order 12866.
comment to amend it is unnecessary. As number of small entities.
a result, EPA finds that there is ‘‘good I. National Technology Transfer and
D. Unfunded Mandates Reform Act
cause’’ under section 553(b)(3)(B) of the Advancement Act (NTTAA)
(UMRA)
Administrative Procedure Act (5 U.S.C. In addition, since this action does not
553(b)(3)(B)) to amend this table Based on EPA’s experience with
proposing and finalizing SNURs, State, involve any technical standards,
without further notice and comment. NTTAA section 12(d) (15 U.S.C. 272
The information collection local, and Tribal governments have not
been impacted by these rulemakings, note), does not apply to this action.
requirements related to this action have
already been approved by OMB and EPA does not have any reasons to J. Executive Order 12898
pursuant to PRA under OMB control believe that any State, local, or Tribal This action does not entail special
number 2070–0012 (EPA ICR No. 574). government will be impacted by this considerations of environmental justice
This action does not impose any burden action. As such, EPA has determined related issues as delineated by
requiring additional OMB approval. If that this action does not impose any Executive Order 12898, entitled
an entity were to submit a SNUN to the enforceable duty, contain any unfunded ‘‘Federal Actions to Address
Agency, the annual burden is estimated mandate, or otherwise have any effect Environmental Justice in Minority
to average between 30 and 170 hours on small governments subject to the Populations and Low-Income
per response. This burden estimate requirements of UMRA sections 202, Populations’’ (59 FR 7629, February 16,
includes the time needed to review 203, 204, or 205 (2 U.S.C. 1501 et seq.). 1994).
instructions, search existing data E. Executive Order 13132
sources, gather and maintain the data XIII. Congressional Review Act
needed, and complete, review, and This action will not have a substantial Pursuant to the Congressional Review
submit the required SNUN. direct effect on States, on the Act (5 U.S.C. 801 et seq.), EPA will
Send any comments about the relationship between the national submit a report containing this rule and
accuracy of the burden estimate, and government and the States, or on the other required information to the U.S.
any suggested methods for minimizing distribution of power and Senate, the U.S. House of
respondent burden, including through responsibilities among the various Representatives, and the Comptroller
the use of automated collection levels of government, as specified in General of the United States prior to
techniques, to the Director, Collection Executive Order 13132, entitled publication of the rule in the Federal
Strategies Division, Office of ‘‘Federalism’’ (64 FR 43255, August 10, Register. This action is not a ‘‘major
Environmental Information (2822T), 1999). rule’’ as defined by 5 U.S.C. 804(2).
Environmental Protection Agency, 1200 F. Executive Order 13175
Pennsylvania Ave. NW., Washington, List of Subjects
DC 20460–0001. Please remember to This action does not have Tribal
implications because it is not expected 40 CFR Part 9
include the OMB control number in any
correspondence, but do not submit any to have substantial direct effects on Environmental protection, Reporting
completed forms to this address. Indian Tribes. This action does not and recordkeeping requirements.
significantly nor uniquely affect the 40 CFR Part 721
C. Regulatory Flexibility Act (RFA) communities of Indian Tribal
On February 18, 2012, EPA certified governments, nor does it involve or Environmental protection, Chemicals,
pursuant to RFA section 605(b) (5 U.S.C. impose any requirements that affect Hazardous substances, Reporting and
601 et seq.), that promulgation of a Indian Tribes. Accordingly, the recordkeeping requirements.
SNUR does not have a significant requirements of Executive Order 13175, Dated: April 5, 2017.
economic impact on a substantial entitled ‘‘Consultation and Coordination Maria J. Doa,
number of small entities where the with Indian Tribal Governments’’ (65 FR Director, Chemical Control Division, Office
following are true: 67249, November 9, 2000), do not apply of Pollution Prevention and Toxics.
1. A significant number of SNUNs to this action.
Therefore, 40 CFR parts 9 and 721 are
would not be submitted by small G. Executive Order 13045 amended as follows:
entities in response to the SNUR.
2. The SNUR submitted by any small This action is not subject to Executive PART 9—[AMENDED]
entity would not cost significantly more Order 13045, entitled ‘‘Protection of
asabaliauskas on DSKBBXCHB2PROD with RULES
than $8,300. Children from Environmental Health ■ 1. The authority citation for part 9
A copy of that certification is Risks and Safety Risks’’ (62 FR 19885, continues to read as follows:
available in the docket for this action. April 23, 1997), because this is not an
Authority: 7 U.S.C. 135 et seq., 136–136y;
This action is within the scope of the economically significant regulatory 15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671;
February 18, 2012 certification. Based action as defined by Executive Order 21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33
on the Economic Analysis discussed in 12866, and this action does not address U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318,
Unit XI. and EPA’s experience environmental health or safety risks 1321, 1326, 1330, 1342, 1344, 1345 (d) and
promulgating SNURs (discussed in the disproportionately affecting children. (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR,
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/13.svg)
![44092 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
1971–1975 Comp. p. 973; 42 U.S.C. 241, ■ 4. Add § 721.10961 to subpart E to ■ 6. Add § 721.10963 to subpart E to
242b, 243, 246, 300f, 300g, 300g–1, 300g–2, read as follows: read as follows:
300g–3, 300g–4, 300g–5, 300g–6, 300j–1,
300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq., § 721.10961 Ethylene glycol ester of an § 721.10963 Alkanoic acid,
6901–6992k, 7401–7671q, 7542, 9601–9657, aromatic substituted propenoic acid tetramethylheteromonocycle ester
11023, 11048. (generic). (generic).
■ 2. In § 9.1, add the following sections (a) Chemical substance and (a) Chemical substance and
in numerical order under the significant new uses subject to reporting. significant new uses subject to reporting.
undesignated center heading (1) The chemical substance identified (1) The chemical substance identified
‘‘Significant New Uses of Chemical generically as ethylene glycol ester of an generically as alkanoic acid,
Substances’’ to read as follows: aromatic substituted propenoic acid tetramethylheteromonocycle ester (PMN
(PMN P–05–436) is subject to reporting P–13–289) is subject to reporting under
§ 9.1 OMB approvals under the Paperwork
Reduction Act.
under this section for the significant this section for the significant new uses
new uses described in paragraph (a)(2) described in paragraph (a)(2) of this
* * * * * of this section. section.
(2) The significant new uses are: (2) The significant new uses are:
OMB
40 CFR citation control No. (i) Release to water. Requirements as (i) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and specified in § 721.90(a)(4), (b)(4), and
(c)(4) (N=10). (c)(4) (N=2).
(ii) [Reserved] (ii) [Reserved]
* * * * * (b) Specific requirements. The (b) Specific requirements. The
provisions of subpart A of this part provisions of subpart A of this part
Significant New Uses of Chemical Sub- apply to this section except as modified apply to this section except as modified
stances by this paragraph. by this paragraph.
* * * * *
(1) Recordkeeping. Recordkeeping (1) Recordkeeping. Recordkeeping
requirements as specified in requirements as specified in
721.10961 ............................. 2070–0012 § 721.125(a) through (c) and (k) are § 721.125(a) through (c) and (k) are
721.10962 ............................. 2070–0012 applicable to manufacturers and applicable to manufacturers and
721.10963 ............................. 2070–0012 processors of this substance. processors of this substance.
721.10964 ............................. 2070–0012 (2) Limitations or revocation of (2) Limitations or revocation of
721.10965 ............................. 2070–0012 certain notification requirements. The certain notification requirements. The
721.10966 ............................. 2070–0012 provisions of § 721.185 apply to this provisions of § 721.185 apply to this
721.10967 ............................. 2070–0012 section. section.
721.10968 ............................. 2070–0012
721.10969 ............................. 2070–0012 ■ 5. Add § 721.10962 to subpart E to ■ 7. Add § 721.10964 to subpart E to
721.10970 ............................. 2070–0012 read as follows: read as follows:
721.10971 ............................. 2070–0012
721.10972 ............................. 2070–0012 § 721.10962 Phosphoric acid, metal salt § 721.10964 Polyether polyester urethane
721.10973 ............................. 2070–0012 (generic). phosphate (generic).
721.10974 ............................. 2070–0012 (a) Chemical substance and (a) Chemical substance and
721.10975 ............................. 2070–0012
721.10976 ............................. 2070–0012 significant new uses subject to reporting. significant new uses subject to reporting.
721.10977 ............................. 2070–0012 (1) The chemical substance identified (1) The chemical substance identified
721.10978 ............................. 2070–0012 generically as phosphoric acid, metal generically as polyether polyester
721.10979 ............................. 2070–0012 salt (PMN P–10–504) is subject to urethane phosphate (PMN P–13–908) is
721.10980 ............................. 2070–0012 reporting under this section for the subject to reporting under this section
721.10981 ............................. 2070–0012 significant new uses described in for the significant new uses described in
721.10982 ............................. 2070–0012 paragraph (a)(2) of this section. paragraph (a)(2) of this section.
721.10983 ............................. 2070–0012 (2) The significant new uses are: (2) The significant new uses are:
721.10984 ............................. 2070–0012
(i) Industrial, commercial, and (i) Industrial, commercial, and
721.10985 ............................. 2070–0012
721.10986 ............................. 2070–0012 consumer activities. Requirements as consumer activities. Requirements as
721.10987 ............................. 2070–0012 specified in § 721.80(j) and (s) (100,000 specified in § 721.80(f), (j) and (s) (1,000
721.10988 ............................. 2070–0012 kilograms). kilograms).
721.10989 ............................. 2070–0012 (ii) [Reserved] (ii) [Reserved]
721.10990 ............................. 2070–0012 (b) Specific requirements. The (b) Specific requirements. The
721.10991 ............................. 2070–0012 provisions of subpart A of this part provisions of subpart A of this part
721.10992 ............................. 2070–0012 apply to this section except as modified apply to this section except as modified
721.10993 ............................. 2070–0012 by this paragraph. by this paragraph.
721.10994 ............................. 2070–0012 (1) Recordkeeping. Recordkeeping (1) Recordkeeping. Recordkeeping
721.10995 ............................. 2070–0012
requirements as specified in requirements as specified in
* * * * * § 721.125(a) through (c) and (i) are § 721.125(a) through (c) and (i) are
applicable to manufacturers and applicable to manufacturers and
processors of this substance. processors of this substance.
asabaliauskas on DSKBBXCHB2PROD with RULES
* * * * * (2) Limitations or revocation of (2) Limitations or revocation of
certain notification requirements. The certain notification requirements. The
PART 721—[AMENDED] provisions of § 721.185 apply to this provisions of § 721.185 apply to this
section. section.
■ 3. The authority citation for part 721 (3) Determining whether a specific use (3) Determining whether a specific use
continues to read as follows: is subject to this section. The provisions is subject to this section. The provisions
Authority: 15 U.S.C. 2604, 2607, and of § 721.1725(b)(1) apply to paragraph of § 721.1725(b)(1) apply to paragraph
2625(c). (a)(2)(i) of this section. (a)(2)(ii) of this section.
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/14.svg)
![44094 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
contained in the corresponding TSCA (2) The significant new uses are: section for the significant new uses
section 5(e) consent order. (i) Hazard communication program. A described in paragraph (a)(2) of this
(ii) Industrial, commercial, and significant new use of the substance is section. The requirements of this rule do
consumer activities. Requirements as any manner or method of manufacture not apply to quantities of the PMN
specified in § 721.80(k). or processing associated with any use of substance after they have been added to
(iii) Release to water. Requirements as the substance without providing risk engine oil.
specified in § 721.90(a)(4), (b)(4), and notification as follows: (i) Hazard communication program. A
(c)(4) (N=20). (A) If as a result of the test data significant new use of the substance is
(b) Specific requirements. The required under TSCA section 5(e) any manner or method of manufacture
provisions of subpart A of this part consent order for the substance, the or processing associated with any use of
apply to this section except as modified employer becomes aware that the the substance without providing risk
by this paragraph. substances may present a risk of injury notification as follows:
(1) Recordkeeping. Recordkeeping to human health or the environment, the (A) If as a result of the test data
requirements as specified in employer must incorporate this new required under TSCA section 5(e)
§ 721.125(a) through (e), (i) and (k) are information, and any information on consent order for the substance, the
applicable to manufacturers and methods for protecting against such risk, employer becomes aware that the
processors of this substance. into an SDS as described in § 721.72(c) substances may present a risk of injury
(2) Limitations or revocation of within 90 days from the time the to human health or the environment, the
certain notification requirements. The employer becomes aware of the new employer must incorporate this new
provisions of § 721.185 apply to this information. If the substance is not information, and any information on
section. being manufactured, processed, or used methods for protecting against such risk,
(3) Determining whether a specific use into an SDS as described in § 721.72(c)
in the employer’s workplace, the
is subject to this section. The provisions within 90 days from the time the
employer must add the new information
of § 721.1725(b)(1) apply to paragraph employer becomes aware of the new
to an SDS before the substance is
(a)(2)(ii) of this section. information. If the substance is not
reintroduced into the workplace.
■ 11. Add § 14;721.10968 to subpart E to (B) The employer must ensure that being manufactured, processed, or used
read as follows: persons who will receive the PMN in the employer’s workplace, the
§ 721.10968 1-Octanamine, 7 (or 8)- substance from the employer, or who employer must add the new information
(aminomethyl)-. have received the PMN substance from to an SDS before the substance is
(a) Chemical substance and the employer within 5 years from the reintroduced into the workplace.
significant new uses subject to reporting. date the employer becomes aware of the (B) The employer must ensure that
(1) The chemical substance identified as new information described in paragraph persons who will receive the PMN
1-octanamine, 7 (or 8)-(aminomethyl)- (a)(2)(i)(A) of this section, are provided substance from the employer, or who
(PMN P–15–279, CAS No. 1613320–81– an SDS containing the information have received the PMN substance from
2) is subject to reporting under this required under paragraph (a)(2)(i)(A) of the employer within 5 years from the
section for the significant new uses this section within 90 days from the date the employer becomes aware of the
described in paragraph (a)(2) of this time the employer becomes aware of the new information described in paragraph
section. new information. (a)(2)(i)(A) of this section, are provided
(2) The significant new uses are: (ii) Industrial, commercial, and an SDS containing the information
(i) Release to water. Requirements as consumer activities. Requirements as required under paragraph (a)(2)(i)(A) of
specified in § 721.90(a)(4), (b)(4), and specified in § 721.80(q). this section within 90 days from the
(c)(4) (N=123). (b) Specific requirements. The time the employer becomes aware of the
(ii) [Reserved] provisions of subpart A of this part new information.
(b) Specific requirements. The apply to this section except as modified (ii) Industrial, commercial, and
provisions of subpart A of this part by this paragraph. consumer activities. Requirements as
apply to this section except as modified (1) Recordkeeping. Recordkeeping specified in § 721.80(q).
by this paragraph. requirements as specified in (iii) Release to water. Requirements as
(1) Recordkeeping. Recordkeeping § 721.125(a) through (c), (h) and (i) are specified in § 721.90(a)(1), (b)(1), and
requirements as specified in applicable to manufacturers and (c)(1).
§ 721.125(a) through (c) and (k) are processors of this substance. (2) [Reserved]
applicable to manufacturers and (2) Limitations or revocation of (b) Specific requirements. The
processors of this substance. certain notification requirements. The provisions of subpart A of this part
(2) Limitations or revocation of provisions of § 721.185 apply to this apply to this section except as modified
certain notification requirements. The section. by this paragraph.
provisions of § 721.185 apply to this (3) Determining whether a specific use (1) Recordkeeping. Recordkeeping
section. is subject to this section. The provisions requirements as specified in
■ 12. Add § 721.10969 to subpart E to of § 721.1725(b)(1) apply to paragraph § 721.125(a) through (c), (h), (i) and (k)
read as follows: (a)(2)(ii) of this section. are applicable to manufacturers and
■ 13. Add § 721.10970 to subpart E to processors of this substance.
§ 721.10969 Substituted alkanolamine read as follows: (2) Limitations or revocation of
ether (generic). certain notification requirements. The
asabaliauskas on DSKBBXCHB2PROD with RULES
(a) Chemical substance and § 721.10970 Butanedioic acid, alkyl amine, provisions of § 721.185 apply to this
significant new uses subject to reporting. dimethylbutyl ester (generic). section.
(1) The chemical substance identified (a) Chemical substance and (3) Determining whether a specific use
generically as substituted alkanolamine significant new uses subject to reporting. is subject to this section. The provisions
ether (PMN P–15–409) is subject to (1) The chemical substance identified of § 721.1725(b)(1) apply to paragraph
reporting under this section for the generically as butanedioic acid, alkyl (a)(2)(ii) of this section.
significant new uses described in amine, dimethylbutyl ester (PMN P–15– ■ 14. Add § 721.10971 to subpart E to
paragraph (a)(2) of this section. 583) is subject to reporting under this read as follows:
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/16.svg)
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44095
§ 721.10971 Carbon nanotube (generic). (1) The chemical substance identified of § 721.1725(b)(1) apply to paragraph
(a) Chemical substance and generically as metal salt of mineral acid, (a)(2)(i) of this section.
significant new uses subject to reporting. reaction products with alumina, ■ 17. Add § 721.10974 to subpart E to
(1) The chemical substance identified aluminum hydroxide, aluminum read as follows:
generically as carbon nanotube (PMN hydroxide oxide (Al(OH)O), silica,
P–15–672) is subject to reporting under titanium oxide (TiO2) and 3- § 721.10974 Halogenated bisphenol A,
polymer with bisphenol A diglycidyl ether
this section for the significant new uses (triethoxysilyl)-1-propanamine (PMN
and epoxidized phenol-formaldehyde resin,
described in paragraph (a)(2) of this P–15–678) is subject to reporting under alkenoate (generic).
section. this section for the significant new uses
(a) Chemical substance and
(2) The significant new uses are: described in paragraph (a)(2) of this
significant new uses subject to reporting.
(i) Protection in the workplace. section.
(1) The chemical substances identified
Requirements as specified in (2) The significant new uses are:
generically as halogenated bisphenol A,
§ 721.63(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), (i) Industrial, commercial, and
polymer with bisphenol A diglycidyl
(a)(4), (a)(6) (particulate), and (c). When consumer activities. Requirements as
ether and epoxidized phenol-
determining which persons are specified in § 721.80(j).
(ii) [Reserved] formaldehyde resin, alkenoate (PMN
reasonably likely to be exposed as
(b) Specific requirements. The P–15–767) is subject to reporting under
required for § 721.63(a)(1) and (a)(4),
provisions of subpart A of this part this section for the significant new uses
engineering control measures (e.g.,
apply to this section except as modified described in paragraph (a)(2) of this
enclosure or confinement of the
by this paragraph. section.
operation, general and local ventilation) (2) The significant new uses are:
or administrative control measures (e.g., (1) Recordkeeping. Recordkeeping
(i) Industrial, commercial, and
workplace policies and procedures) requirements as specified in
consumer activities. Requirements as
shall be considered and implemented to § 721.125(a) through (c) and (i) are
specified in § 721.80(j), (o) and (s)
prevent exposure, where feasible. A applicable to manufacturers and
(10,000 kilograms).
National Institute for Occupational processors of this substance. (ii) [Reserved]
Safety and Health (NIOSH)-certified (2) Limitations or revocation of (b) Specific requirements. The
respirators with an N–100, P–100, or certain notification requirements. The provisions of subpart A of this part
R–100 cartridge meet the requirements provisions of § 721.185 apply to this apply to this section except as modified
of § 721.63(a)(4). section. by this paragraph.
(ii) Industrial, commercial, and (3) Determining whether a specific use (1) Recordkeeping. Recordkeeping
consumer activities. Requirements as is subject to this section. The provisions requirements as specified in
specified in § 721.80. It is a significant of § 721.1725(b)(1) apply to paragraph § 721.125(a) through (c) and (i) are
new use to process or use the chemical (a)(2)(i) of this section. applicable to manufacturers and
substance other than as an aqueous ■ 16. Add § 721.10973 to subpart E to processors of this substance.
slurry, wet form, or a contained dry read as follows: (2) Limitations or revocation of
form as described in the PMN. certain notification requirements. The
(iii) Disposal. Requirements as § 721.10973 Halogenated bisphenol A,
polymer with epichlorohydrin, alkenoate
provisions of § 721.185 apply to this
specified in § 721.85(a)(1), (a)(2), (b)(1), (generic). section.
(b)(2), (c)(1), and (c)(2). (3) Determining whether a specific use
(iv) Release to water. Requirements as (a) Chemical substance and
is subject to this section. The provisions
specified in § 721.90(a)(1), (b)(1), and significant new uses subject to reporting.
of § 721.1725(b)(1) apply to paragraph
(c)(1). (1) The chemical substance identified
(a)(2)(i) of this section.
(b) Specific requirements. The generically as halogenated bisphenol A,
■ 18. Add § 721.10975 to subpart E to
provisions of subpart A of this part polymer with epichlorohydrin,
alkenoate (PMN P–15–766) is subject to read as follows:
apply to this section except as modified
by this paragraph. reporting under this section for the § 721.10975 Silicon, tris[dialkyl phenyl]-
(1) Recordkeeping. Recordkeeping significant new uses described in dialkyl-dioxoalkane-naphthalene
requirements as specified in paragraph (a)(2) of this section. disulfonate (generic).
§ 721.125(a) through (e) and (i) through (2) The significant new uses are: (a) Chemical substance and
(k) are applicable to manufacturers and (i) Industrial, commercial, and significant new uses subject to reporting.
processors of this substance. consumer activities. Requirements as (1) The chemical substance identified
(2) Limitations or revocation of specified in § 721.80(j), (o) and (s) generically as silicon, tris[dialkyl
certain notification requirements. The (10,000 kilograms). phenyl]-dialkyl-dioxoalkane-
provisions of § 721.185 apply to this (ii) [Reserved] naphthalene disulfonate (PMN P–16–14)
section. (b) Specific requirements. The is subject to reporting under this section
(3) Determining whether a specific use provisions of subpart A of this part for the significant new uses described in
is subject to this section. The provisions apply to this section except as modified paragraph (a)(2) of this section.
of § 721.1725(b)(1) apply to paragraph by this paragraph. (2) The significant new uses are:
(a)(2)(iii) of this section. (1) Recordkeeping. Recordkeeping (i) Industrial, commercial, and
requirements as specified in consumer activities. Requirements as
■ 15. Add § 721.10972 to subpart E to
§ 721.125(a) through (c) and (i) are specified in § 721.80(j). The significant
asabaliauskas on DSKBBXCHB2PROD with RULES
read as follows: applicable to manufacturers and new use is use other than as described
§ 721.10972 Metal salt of mineral acid, processors of this substance. in PMN–16–14 where the surface water
reaction products with alumina, aluminum (2) Limitations or revocation of concentrations described in paragraph
hydroxide, aluminum hydroxide oxide certain notification requirements. The (a)(3)(i) are exceeded.
(Al(OH)O), silica, titanium oxide (TiO2) and provisions of § 721.185 apply to this (ii) [Reserved]
3-(triethoxysilyl)-1-propanamine (generic). section. (3) The significant new uses for any
(a) Chemical substance and (3) Determining whether a specific use use other than as described in PMN–16–
significant new uses subject to reporting. is subject to this section. The provisions 14:
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/17.svg)
![44096 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
(i) Release to water. Requirements as (ii) [Reserved] apply to this section except as modified
specified in § 721.90(a)(4), (b)(4), and (b) Specific requirements. The by this paragraph.
(c)(4) (N=6). provisions of subpart A of this part (1) Recordkeeping. Recordkeeping
(ii) [Reserved] apply to this section except as modified requirements as specified in
(b) Specific requirements. The by this paragraph. § 721.125(a) through (c) and (i) are
provisions of subpart A of this part (1) Recordkeeping. Recordkeeping applicable to manufacturers and
apply to this section except as modified requirements as specified in processors of this substance.
by this paragraph. § 721.125(a) through (c) and (k) are (2) Limitations or revocation of
(1) Recordkeeping. Recordkeeping applicable to manufacturers and certain notification requirements. The
requirements as specified in processors of this substance. provisions of § 721.185 apply to this
§ 721.125(a) through (c), (i), and (k) are (2) Limitations or revocation of section.
applicable to manufacturers and certain notification requirements. The ■ 23. Add § 721.10980 to subpart E to
processors of this substance. provisions of § 721.185 apply to this read as follows:
(2) Limitations or revocation of section.
certain notification requirements. The ■ 21. Add § 721.10978 to subpart E to § 721.10980 Perfluoropolyether modified
provisions of § 721.185 apply to this read as follows: organosilane (generic).
section. (a) Chemical substance and
§ 721.10978 Fattyalkylaminopropanoate significant new uses subject to reporting.
(3) Determining whether a specific use
ester (generic).
is subject to this section. The provisions (1) The chemical substance identified
of § 721.1725(b)(1) apply to paragraph (a) Chemical substance and generically as perfluoropolyether
(a)(2)(ii) of this section. significant new uses subject to reporting. modified organosilane (PMN P–16–94)
(1) The chemical substance identified is subject to reporting under this section
■ 19. Add § 721.10976 to subpart E to
generically as for the significant new uses described in
read as follows: fattyalkylaminopropanoate ester (PMN paragraph (a)(2) of this section.
§ 721.10976 Tar acids fraction (generic). P–16–60) is subject to reporting under (2) The significant new uses are:
(a) Chemical substance and this section for the significant new uses (i) Industrial, commercial, and
significant new uses subject to reporting. described in paragraph (a)(2) of this consumer activities. Requirements as
(1) The chemical substance identified section. specified in § 721.80(s) (500 kilograms).
(2) The significant new uses are: (ii) [Reserved]
generically as tar acids fraction (PMN (i) Release to water. Requirements as
P–16–40) is subject to reporting under (b) Specific requirements. The
specified in § 721.90(a)(4), (b)(4), and
this section for the significant new uses provisions of subpart A of this part
(c)(4) (N=1).
described in paragraph (a)(2) of this apply to this section except as modified
(ii) [Reserved]
section. (b) Specific requirements. The by this paragraph.
(2) The significant new uses are: provisions of subpart A of this part (1) Recordkeeping. Recordkeeping
(i) Release to water. Requirements as apply to this section except as modified requirements as specified in
specified in § 721.90(a)(4), (b)(4), and by this paragraph. § 721.125(a) through (c) and (i) are
(c)(4) (N=45). (1) Recordkeeping. Recordkeeping applicable to manufacturers and
(ii) [Reserved] requirements as specified in processors of this substance.
(b) Specific requirements. The § 721.125(a) through (c) and (k) are (2) Limitations or revocation of
provisions of subpart A of this part applicable to manufacturers and certain notification requirements. The
apply to this section except as modified processors of this substance. provisions of § 721.185 apply to this
by this paragraph. (2) Limitations or revocation of section.
(1) Recordkeeping. Recordkeeping certain notification requirements. The ■ 24. Add § 721.10981 to subpart E to
requirements as specified in provisions of § 721.185 apply to this read as follows:
§ 721.125(a) through (c) and (k) are section.
applicable to manufacturers and § 721.10981 Modified phenol-formaldehyde
■ 22. Add § 721.10979 to subpart E to resin (generic).
processors of this substance. read as follows:
(2) Limitations or revocation of (a) Chemical substance and
certain notification requirements. The § 721.10979 Boron sodium oxide significant new uses subject to reporting.
provisions of § 721.185 apply to this (B5NaO8), labeled with boron-10. (1) The chemical substance identified
section. (a) Chemical substance and generically as modified phenol-
■ 20. Add § 721.10977 to subpart E to significant new uses subject to reporting. formaldehyde resin (PMN P–16–95) is
read as follows: (1) The chemical substance identified as subject to reporting under this section
boron sodium oxide (B5NaO8), labeled for the significant new uses described in
§ 721.10977 Dialkyl fattyalkylamino with boron-10 (PMN P–16–70, CAS No. paragraph (a)(2) of this section.
propanamide alkylamine (generic). 200443–98–7) is subject to reporting (2) The significant new uses are:
(a) Chemical substance and under this section for the significant (i) Industrial, commercial, and
significant new uses subject to reporting. new uses described in paragraph (a)(2) consumer activities. Requirements as
(1) The chemical substance identified of this section. specified in § 721.80(j).
generically as dialkyl fattyalkylamino (2) The significant new uses are: (ii) Release to water. Requirements as
propanamide alkylamine (PMN P–16– (i) Industrial, commercial, and specified in § 721.90(a)(4), (b)(4), and
asabaliauskas on DSKBBXCHB2PROD with RULES
59) is subject to reporting under this consumer activities. Requirements as (c)(4) (N=96).
section for the significant new uses specified in § 721.80. A significant new (b) Specific requirements. The
described in paragraph (a)(2) of this use is any use of the substance other provisions of subpart A of this part
section. than as an emergency shutdown coolant apply to this section except as modified
(2) The significant new uses are: in boiler water reactors. by this paragraph.
(i) Release to water. Requirements as (ii) [Reserved] (1) Recordkeeping. Recordkeeping
specified in § 721.90(a)(4), (b)(4), and (b) Specific requirements. The requirements as specified in
(c)(4) (N=1). provisions of subpart A of this part § 721.125(a) through (c), (i), and (k) are
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00044 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/18.svg)
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44097
applicable to manufacturers and (b) Specific requirements. The apply to this section except as modified
processors of this substance. provisions of subpart A of this part by this paragraph.
(2) Limitations or revocation of apply to this section except as modified (1) Recordkeeping. Recordkeeping
certain notification requirements. The by this paragraph. requirements as specified in
provisions of § 721.185 apply to this (1) Recordkeeping. Recordkeeping § 721.125(a) through (c) and (k) are
section. requirements as specified in applicable to manufacturers and
(3) Determining whether a specific use § 721.125(a) through (c) and (k) are processors of these substances.
is subject to this section. The provisions applicable to manufacturers and (2) Limitations or revocation of
of § 721.1725(b)(1) apply to paragraph processors of this substance. certain notification requirements. The
(a)(2)(i) of this section. (2) Limitations or revocation of provisions of § 721.185 apply to this
■ 25. Add § 721.10982 to subpart E to certain notification requirements. The section.
read as follows: provisions of § 721.185 apply to this
■ 29. Add § 721.10986 to subpart E to
section.
§ 721.10982 Disubstituted benzene alkanal
read as follows:
■ 27. Add § 721.10984 to subpart E to
(generic). read as follows: § 721.10986 Nanocarbon (generic).
(a) Chemical substance and (a) Chemical substance and
significant new uses subject to reporting. § 721.10984 2-Pyridinecarboxylic acid, 4,5-
dichloro-6-(4-chloro-2-fluoro-3- significant new uses subject to reporting.
(1) The chemical substance identified methoxyphenyl)-. (1) The chemical substance identified
generically as disubstituted benzene generically as nanocarbon (PMN P–16–
alkanal (PMN P–16–101) is subject to (a) Chemical substance and
significant new uses subject to reporting. 170) is subject to reporting under this
reporting under this section for the section for the significant new uses
significant new uses described in (1) The chemical substance identified as
2-pyridinecarboxylic acid, 4,5-dichloro- described in paragraph (a)(2) of this
paragraph (a)(2) of this section. section. The requirements of this rule do
(2) The significant new uses are: 6-(4-chloro-2-fluoro-3-methoxyphenyl)-
(PMN P–16–104, CAS No. 1546765–39– not apply when the PMN substance is
(i) Protection in the workplace. incorporated into the composite
Requirements as specified in 2) is subject to reporting under this
section for the significant new uses material allowed by the section 5(e)
§ 721.63(a)(2)(i), (a)(3), (b) consent order.
(concentration set at 1.0 percent), and described in paragraph (a)(2) of this
section. (2) The significant new uses are:
(c). (i) Protection in the workplace.
(2) The significant new uses are:
(ii) Industrial commercial, and (i) Industrial, commercial, and Requirements as specified in
consumer activities. Requirements as consumer activities. Requirements as § 721.63(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3),
specified in § 721.80(j). specified in § 721.80(g). (a)(4), (a)(6) (particulate), and (c). When
(b) Specific requirements. The (ii) Release to water. Requirements as determining which persons are
provisions of subpart A of this part specified in § 721.90(a)(4), (b)(4), and reasonably likely to be exposed as
apply to this section except as modified (c)(4) (N=8). required for § 721.63(a)(1) and (a)(4),
by this paragraph. (b) Specific requirements. The engineering control measures (e.g.,
(1) Recordkeeping. Recordkeeping provisions of subpart A of this part enclosure or confinement of the
requirements as specified in apply to this section except as modified operation, general and local ventilation)
§ 721.125(a) through (e) and (i) are by this paragraph. or administrative control measures (e.g.,
applicable to manufacturers and (1) Recordkeeping. Recordkeeping workplace policies and procedures)
processors of this substance. requirements as specified in shall be considered and implemented to
(2) Limitations or revocation of § 721.125(a) through (c), (i), and (k) are prevent exposure, where feasible. A
certain notification requirements. The applicable to manufacturers and National Institute for Occupational
provisions of § 721.185 apply to this processors of this substance. Safety and Health (NIOSH)-certified
section. (2) Limitations or revocation of
(3) Determining whether a specific use respirators with an N–100, P–100, or
certain notification requirements. The R–100 cartridge meet the requirements
is subject to this section. The provisions provisions of § 721.185 apply to this
of § 721.1725(b)(1) apply to paragraph of § 721.63(a)(4).
section. (ii) Industrial, commercial, and
(a)(2)(ii) of this section. ■ 28. Add § 721.10985 to subpart E to consumer activities. Requirements as
■ 26. Add § 721.10983 to subpart E to read as follows: specified in § 721.80(k) and (q). A
read as follows: significant new use is any use involving
§ 721.10985 Dialkylamino alkylamide inner
§ 721.10983 Phthalic anhydride, polymer salt (generic). an application method that generates a
with alkylene glycol and alkanepolyol, (a) Chemical substance and significant vapor, mist or aerosol.
acrylate (generic). new uses subject to reporting. (1) The (iii) Disposal. Requirements as
(a) Chemical substance and chemical substances identified specified in § 721.85(a)(1), (a)(2), (b)(1),
significant new uses subject to reporting. generically as dialkylamino alkylamide (b)(2), (c)(1), and (c)(2).
(1) The chemical substance identified inner salt (PMNs P–16–136, P–16–139 (iv) Release to water. Requirements as
generically as phthalic anhydride, and P–16–140) are subject to reporting specified in § 721.90(a)(1), (b)(1), and
polymer with alkylene glycol and under this section for the significant (c)(1).
alkanepolyol, acrylate (PMN P–16–102) new uses described in paragraph (a)(2) (b) Specific requirements. The
asabaliauskas on DSKBBXCHB2PROD with RULES
is subject to reporting under this section of this section. provisions of subpart A of this part
for the significant new uses described in (2) The significant new uses are: apply to this section except as modified
paragraph (a)(2) of this section. (i) Release to water. Requirements as by this paragraph.
(2) The significant new uses are: specified in § 721.90(a)(4), (b)(4), and (1) Recordkeeping. Recordkeeping
(i) Release to water. Requirements as (c)(4) (N=1). requirements as specified in
specified in § 721.90(a)(4), (b)(4), and (ii) [Reserved] § 721.125(a) through (e) and (i) through
(c)(4) (N=1). (b) Specific requirements. The (k) are applicable to manufacturers and
(ii) [Reserved] provisions of subpart A of this part processors of this substance.
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/19.svg)
![44098 Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations
(2) Limitations or revocation of (1) The chemical substance identified ■ 33. Add § 721.10990 to subpart E to
certain notification requirements. The generically as alkanoic acids, esters with read as follows:
provisions of § 721.185 apply to this alkanetriol (PMN P–16–179) is subject
section. to reporting under this section for the § 721.10990 Manganese, [.mu.-(acetato-
.kappa.O:.kappa.O’)]bis[.mu.-(2-
(3) Determining whether a specific use significant new uses described in ethylhexanoato-
is subject to this section. The provisions paragraph (a)(2) of this section. .kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
of § 721.1725(b)(1) apply to paragraph (2) The significant new uses are: trimethyl-1H-1,4,7-triazonine-
(a)(2)(iii) of this section. (i) Release to water. Requirements as .kappa.N1,.kappa.N4,.kappa.N7)di- (P–16–
■ 30. Add § 721.10987 to subpart E to specified in § 721.90(a)(4), (b)(4), and 182, chemical B).
read as follows: (c)(4) (N=1). (a) Chemical substance and
(ii) [Reserved]
significant new uses subject to reporting.
§ 721.10987 Barium molybdenum niobium (b) Specific requirements. The
provisions of subpart A of this part (1) The chemical substance identified as
tantalum tellurium vanadium zinc oxide.
apply to this section except as modified manganese, [.mu.-(acetato-
(a) Chemical substance and .kappa.O:.kappa.O’)]bis[.mu.-(2-
significant new uses subject to reporting. by this paragraph.
(1) Recordkeeping. Recordkeeping ethylhexanoato-
(1) The chemical substance identified as .kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
barium molybdenum niobium tantalum requirements as specified in
§ 721.125(a) through (c) and (k) are trimethyl-1H-1,4,7-triazonine-
tellurium vanadium zinc oxide (PMN .kappa.N1,.kappa.N4,.kappa.N7)di-
P–16–177, CAS No. 1440529–21–4) is applicable to manufacturers and
processors of this substance. (PMN P–16–182, chemical B; CAS No.
subject to reporting under this section 2020407–63–8) is subject to reporting
for the significant new uses described in (2) Limitations or revocation of
certain notification requirements. The under this section for the significant
paragraph (a)(2) of this section. new uses described in paragraph (a)(2)
(2) The significant new uses are: provisions of § 721.185 apply to this
section. of this section.
(i) Protection in the workplace. (2) The significant new uses are:
Requirements as specified in ■ 32. Add § 721.10989 to subpart E to
read as follows: (i) Protection in the workplace.
§ 721.63(a)(4), (a)(6)(i), (a)(6)(ii), (b) Requirements as specified in
(concentration set at 1.0 percent) and § 721.10989 Manganese, tris[.mu.-(2- § 721.63(a)(1), (a)(3), and (b)
(c). When determining which persons ethylhexanoato- (concentration set at 1.0 percent).
are reasonably likely to be exposed as .kappa.O:.kappa.O’)]bis(octahydro-1,4,7- (ii) Industrial, commercial, and
required for § 721.63(a)(4), engineering trimethyl-1H-1,4,7-triazonine- consumer activities. Requirements as
control measures (e.g., enclosure or .kappa.N1,.kappa.N4,.kappa.N7)di- (P–16– specified in § 721.80(f) and (j) (a
confinement of the operation, general 182, chemical A).
significant new use is any manufacture
and local ventilation) or administrative (a) Chemical substance and at a concentration of greater than 10%
control measures (e.g., workplace significant new uses subject to reporting. of the PMN substance in any
policies and procedures) shall be (1) The chemical substance identified as formulation).
considered and implemented to prevent manganese, tris[.mu.-(2-ethylhexanoato- (b) Specific requirements. The
exposure, where feasible. The following .kappa.O:.kappa.O’)]bis(octahydro-1,4,7- provisions of subpart A of this part
National Institute for Occupational trimethyl-1H-1,4,7-triazonine- apply to this section except as modified
Safety and Health (NIOSH)-certified .kappa.N1,.kappa.N4,.kappa.N7)di- by this paragraph.
respirators with an assigned protection (PMN P–16–182, chemical A; CAS No. (1) Recordkeeping. Recordkeeping
factor (APF) of at least 10 meet the 2020407–62–7) is subject to reporting requirements as specified in
requirements of § 721.63(a)(4). under this section for the significant § 721.125(a) through (e) and (i) are
(ii) Industrial, commercial, and new uses described in paragraph (a)(2) applicable to manufacturers and
consumer activities. Requirements as of this section. processors of this substance.
specified in 721.80(f) and (j). (2) The significant new uses are: (2) Limitations or revocation of
(b) Specific requirements. The (i) Protection in the workplace. certain notification requirements. The
provisions of subpart A of this part Requirements as specified in provisions of § 721.185 apply to this
apply to this section except as modified § 721.63(a)(1), (a)(3), and (b) section.
by this paragraph. (concentration set at 1.0 percent).
■ 34. Add § 721.10991 to subpart E to
(1) Recordkeeping. Recordkeeping (ii) Industrial, commercial, and
consumer activities. Requirements as read as follows:
requirements as specified in
§ 721.125(a) through (d) and (i) are specified in § 721.80(f) and (j) (a § 721.10991 Manganese, bis[.mu.-(acetato-
applicable to manufacturers and significant new use is any manufacture .kappa.O:.kappa.O’)][.mu.-(2-
processors of this substance. at a concentration of greater than 10% ethylhexanoato-
(2) Limitations or revocation of of the PMN substance in any .kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
certain notification requirements. The formulation). trimethyl-1H-1,4,7-triazonine-
provisions of § 721.185 apply to this (b) Specific requirements. The .kappa.N1,.kappa.N4,.kappa.N7)di- (P–16–
provisions of subpart A of this part 182, chemical C).
section.
(3) Determining whether a specific use apply to this section except as modified (a) Chemical substance and
is subject to this section. The provisions by this paragraph. significant new uses subject to reporting.
of § 721.1725(b)(1) apply to paragraph (1) Recordkeeping. Recordkeeping (1) The chemical substance identified as
asabaliauskas on DSKBBXCHB2PROD with RULES
(a)(2)(i) of this section. requirements as specified in manganese, bis[.mu.-(acetato-
■ 31. Add § 721.10988 to subpart E to § 721.125(a) through (e) and (i) are .kappa.O:.kappa.O’)][.mu.-(2-
read as follows: applicable to manufacturers and ethylhexanoato-
processors of this substance. .kappa.O:.kappa.O’)]bis(octahydro-1,4,7-
§ 721.10988 Alkanoic acids, esters with (2) Limitations or revocation of trimethyl-1H-1,4,7-triazonine-
alkanetriol (generic). certain notification requirements. The .kappa.N1,.kappa.N4,.kappa.N7)di-
(a) Chemical substance and provisions of § 721.185 apply to this (PMN P–16–182, chemical C; CAS No.
significant new uses subject to reporting. section. 2020407–64–9) is subject to reporting
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00046 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/20.svg)
![Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Rules and Regulations 44099
under this section for the significant (2) Limitations or revocation of provisions of § 721.185 apply to this
new uses described in paragraph (a)(2) certain notification requirements. The section.
of this section. provisions of § 721.185 apply to this ■ 38. Add § 721.10995 to subpart E to
(2) The significant new uses are: section. read as follows:
(i) Protection in the workplace. ■ 36. Add § 721.10993 to subpart E to
Requirements as specified in read as follows: § 721.10995 Lecithins, soya,
§ 721.63(a)(1), (a)(3), and (b) hydrogenated.
(concentration set at 1.0 percent). § 721.10993 Aryl polyolefin (generic). (a) Chemical substance and
(ii) Industrial, commercial, and (a) Chemical substance and significant new uses subject to reporting.
consumer activities. Requirements as significant new uses subject to reporting. (1) The chemical substance identified as
specified in § 721.80(f) and (j) (a (1) The chemical substance identified lecithins, soya, hydrogenated (PMN P–
significant new use is any manufacture generically as aryl polyolefin (PMN P– 16–272, CAS No. 308068–11–3) is
at a concentration of greater than 10% 16–190) is subject to reporting under subject to reporting under this section
of the PMN substance in any this section for the significant new uses for the significant new uses described in
formulation). described in paragraph (a)(2) of this paragraph (a)(2) of this section.
(b) Specific requirements. The section. (2) The significant new uses are:
provisions of subpart A of this part (2) The significant new uses are: (i) Release to water. Requirements as
apply to this section except as modified (i) Protection in the workplace. specified in § 721.90(a)(4), (b)(4), and
by this paragraph. Requirements as specified in (c)(4) (N=1).
(1) Recordkeeping. Recordkeeping § 721.63(a)(1), (a)(3), and (b) (ii) [Reserved]
requirements as specified in (concentration set at 1.0 percent). (b) Specific requirements. The
§ 721.125(a) through (e) and (i) are (ii) Industrial, commercial, and provisions of subpart A of this part
applicable to manufacturers and consumer activities. Requirements as apply to this section except as modified
processors of this substance. specified in § 721.80(j). by this paragraph.
(2) Limitations or revocation of (b) Specific requirements. The (1) Recordkeeping. Recordkeeping
certain notification requirements. The provisions of subpart A of this part requirements as specified in
provisions of § 721.185 apply to this apply to this section except as modified § 721.125(a) through (c) and (k) are
section. by this paragraph. applicable to manufacturers and
■ 35. Add § 721.10992 to subpart E to (1) Recordkeeping. Recordkeeping processors of this substance.
read as follows: requirements as specified in (2) Limitations or revocation of
§ 721.125(a) through (d) and (i) are certain notification requirements. The
§ 721.10992 Manganese, tris[.mu.-(acetato- applicable to manufacturers and provisions of § 721.185 apply to this
.kappa.O:.kappa.O’)]bis(octahydro-1,4,7- processors of this substance. section.
trimethyl-1H-1,4,7-triazonine- (2) Limitations or revocation of [FR Doc. 2017–20158 Filed 9–20–17; 8:45 am]
.kappa.N1,.kappa.N4,.kappa.N7)di- (P–16– certain notification requirements. The
182, chemical D). BILLING CODE 6560–50–P
provisions of § 721.185 apply to this
(a) Chemical substance and section.
significant new uses subject to reporting. (3) Determining whether a specific use ENVIRONMENTAL PROTECTION
(1) The chemical substance identified as is subject to this section. The provisions AGENCY
manganese, tris[.mu.-(acetato- of § 721.1725(b)(1) apply to paragraph
.kappa.O:.kappa.O’)]bis(octahydro-1,4,7- (a)(2)(ii) of this section. 40 CFR Part 52
trimethyl-1H-1,4,7-triazonine- ■ 37. Add § 721.10994 to subpart E to
.kappa.N1,.kappa.N4,.kappa.N7)di- [EPA–R02–OAR–2017–0044; FRL–9968–05–
read as follows: Region 2]
(PMN P–16–182, chemical D; CAS No.
2020407–65–0) is subject to reporting § 721.10994 Melamine nitrate (generic).
Approval of Air Quality Implementation
under this section for the significant (a) Chemical substance and Plans; New Jersey, 2011 Periodic
new uses described in paragraph (a)(2) significant new uses subject to reporting. Emission Inventory SIP for the Ozone
of this section. (1) The chemical substance identified Nonattainment and PM2.5/Regional
(2) The significant new uses are: generically as melamine nitrate (PMN Haze Areas
(i) Protection in the workplace. P–16–260) is subject to reporting under
Requirements as specified in this section for the significant new uses AGENCY: Environmental Protection
§ 721.63(a)(1), (a)(3), and (b) described in paragraph (a)(2) of this Agency (EPA).
(concentration set at 1.0 percent). section. ACTION: Final rule.
(ii) Industrial, commercial, and (2) The significant new uses are:
consumer activities. Requirements as (i) Release to water. Requirements as SUMMARY: The Environmental Protection
specified in § 721.80(f) and (j) (a specified in § 721.90(a)(4), (b)(4), and Agency (EPA) is approving a State
significant new use is any manufacture (c)(4) (N=14). Implementation Plan (SIP) revision
at a concentration of greater than 10% (ii) [Reserved] submitted by the New Jersey
of the PMN substance in any (b) Specific requirements. The Department of Environmental
formulation). provisions of subpart A of this part Protection. The SIP revision consists of
(b) Specific requirements. The apply to this section except as modified the following: 2011 calendar year ozone
asabaliauskas on DSKBBXCHB2PROD with RULES
provisions of subpart A of this part by this paragraph. precursor emission inventories for
apply to this section except as modified (1) Recordkeeping. Recordkeeping volatile organic compounds (VOC),
by this paragraph. requirements as specified in oxides of nitrogen (NOX) and carbon
(1) Recordkeeping. Recordkeeping § 721.125(a) through (c) and (k) are monoxide (CO) for the New York-
requirements as specified in applicable to manufacturers and Northern New Jersey-Long Island area
§ 721.125(a) through (e) and (i) are processors of this substance. classified as Moderate ozone
applicable to manufacturers and (2) Limitations or revocation of nonattainment for the 2008 8-hour
processors of this substance. certain notification requirements. The ozone standard, and the Philadelphia-
VerDate Sep<11>2014 16:39 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00047 Fmt 4700 Sfmt 4700 E:\FR\FM\21SER1.SGM 21SER1](https://thefederalregister.org/doc/82_FR_44261/page/21.svg)
Document Created: 2018-10-24 14:33:59
Document Modified: 2018-10-24 14:33:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Rules and Regulations | |
| Action | Direct final rule. | |
| Dates | This rule is effective on November 20, 2017. For purposes of judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on October 5, 2017. | |
| Contact | For technical information contact: Kenneth Moss, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW. Washington, DC 20460-0001; telephone number: | |
| FR Citation | 82 FR 44079 | |
| RIN Number | 2070-AB27 | |
| CFR Citation | 40
CFR
721 40 CFR 9 | |
| CFR Associated | Chemicals; Hazardous Substances; Environmental Protection and Reporting and Recordkeeping Requirements |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR